CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: Muraglitazar
Accession: CHEBI:188851
browse the term
Synonyms: exact_synonym: 2-[(4-methoxyphenoxy)carbonyl-[[4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenyl]methyl]amino]acetic acid
related_synonym: Formula=C29H28N2O7; InChI=1S/C29H28N2O7/c1-20-26(30-28(37-20)22-6-4-3-5-7-22)16-17-36-24-10-8-21(9-11-24)18-31(19-27(32)33)29(34)38-25-14-12-23(35-2)13-15-25/h3-15H,16-19H2,1-2H3,(H,32,33); InChIKey=IRLWJILLXJGJTD-UHFFFAOYSA-N; SMILES=O(CCC=1N=C(OC1C)C2=CC=CC=C2)C3=CC=C(CN(CC(O)=O)C(OC4=CC=C(OC)C=C4)=O)C=C3
xref: CAS:331741-94-7; Chemspider:178524; DrugBank:DB06510; KEGG:D05091
xref_mesh: MESH:C500085
G
A3galt2
alpha 1,3-galactosyltransferase 2
decreases expression
EXP
muraglitazar results in decreased expression of A3GALT2 mRNA
CTD
PMID:21515302
NCBI chr 5:141,101,329...141,113,760
Ensembl chr 5:141,107,983...141,115,641
G
Abcc2
ATP binding cassette subfamily C member 2
decreases expression
EXP
muraglitazar results in decreased expression of ABCC2 mRNA
CTD
PMID:21515302
NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238
G
Abcd3
ATP binding cassette subfamily D member 3
increases expression
EXP
muraglitazar results in increased expression of ABCD3 mRNA
CTD
PMID:21515302
NCBI chr 2:209,852,087...209,905,763
Ensembl chr 2:209,852,087...209,906,020
G
Abcg5
ATP binding cassette subfamily G member 5
increases expression
EXP
muraglitazar results in increased expression of ABCG5 mRNA
CTD
PMID:21515302
NCBI chr 6:9,965,118...9,990,563
Ensembl chr 6:9,965,118...9,990,563
G
Abhd1
abhydrolase domain containing 1
increases expression
EXP
muraglitazar results in increased expression of ABHD1 mRNA
CTD
PMID:21515302
NCBI chr 6:25,422,526...25,427,514
Ensembl chr 6:25,422,526...25,427,514
G
Abo
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase
increases expression
EXP
muraglitazar results in increased expression of ABO mRNA
CTD
PMID:21515302
NCBI chr 3:10,162,087...10,182,835
Ensembl chr 3:10,162,096...10,191,423
G
Acaa1a
acetyl-CoA acyltransferase 1A
increases expression
EXP
muraglitazar results in increased expression of ACAA1 mRNA
CTD
PMID:21515302
NCBI chr 8:119,079,401...119,088,626
Ensembl chr 8:119,079,775...119,088,624
G
Acaa2
acetyl-CoA acyltransferase 2
increases expression
EXP
muraglitazar results in increased expression of ACAA2 mRNA
CTD
PMID:21515302
NCBI chr18:68,345,136...68,373,246
Ensembl chr18:68,345,012...68,373,249
G
Acadm
acyl-CoA dehydrogenase medium chain
increases expression
EXP
muraglitazar results in increased expression of ACADM mRNA
CTD
PMID:21515302
NCBI chr 2:242,858,865...242,883,036
Ensembl chr 2:242,858,865...242,883,147
G
Acadvl
acyl-CoA dehydrogenase, very long chain
increases expression
EXP
muraglitazar results in increased expression of ACADVL mRNA
CTD
PMID:21515302
NCBI chr10:54,732,875...54,738,102
Ensembl chr10:54,732,469...54,738,075
G
Acat1
acetyl-CoA acetyltransferase 1
increases expression
EXP
muraglitazar results in increased expression of ACAT1 mRNA
CTD
PMID:21515302
NCBI chr 8:53,979,813...54,008,861
Ensembl chr 8:53,979,813...54,008,855
G
Aco1
aconitase 1
increases expression
EXP
muraglitazar results in increased expression of ACO1 mRNA
CTD
PMID:21515302
NCBI chr 5:55,259,841...55,315,872
Ensembl chr 5:55,259,827...55,316,391
G
Acot1
acyl-CoA thioesterase 1
increases expression
EXP
muraglitazar results in increased expression of ACOT1 mRNA
CTD
PMID:21515302
NCBI chr 6:103,636,173...103,644,167
Ensembl chr 6:103,636,041...103,644,163
G
Acot12
acyl-CoA thioesterase 12
increases expression
EXP
muraglitazar results in increased expression of ACOT12 mRNA
CTD
PMID:21515302
NCBI chr 2:22,986,867...23,027,538
Ensembl chr 2:22,986,626...23,027,536
G
Acot2
acyl-CoA thioesterase 2
increases expression
EXP
muraglitazar results in increased expression of ACOT2 mRNA
CTD
PMID:21515302
NCBI chr 6:103,611,738...103,619,404
Ensembl chr 6:103,611,544...103,619,245
G
Acot7
acyl-CoA thioesterase 7
increases expression
EXP
muraglitazar results in increased expression of ACOT7 mRNA
CTD
PMID:21515302
NCBI chr 5:162,686,562...162,779,309
Ensembl chr 5:162,684,645...162,779,309
G
Acox1
acyl-CoA oxidase 1
increases expression multiple interactions
EXP ISO
muraglitazar results in increased expression of ACOX1 mRNA [muraglitazar co-treated with Oleic Acid] results in increased expression of ACOX1 mRNA
CTD
PMID:21515302 PMID:24534255
NCBI chr10:101,406,197...101,431,252
Ensembl chr10:101,406,197...101,431,232
G
Acp3
acid phosphatase 3
increases expression
EXP
muraglitazar results in increased expression of ACP3 mRNA
CTD
PMID:21515302
NCBI chr 8:104,905,570...104,956,146
Ensembl chr 8:104,905,586...104,954,236
G
Acsl1
acyl-CoA synthetase long-chain family member 1
increases expression
EXP
muraglitazar results in increased expression of ACSL1 mRNA
CTD
PMID:21515302
NCBI chr16:45,755,246...45,821,541
Ensembl chr16:45,755,254...45,821,541
G
Acsl3
acyl-CoA synthetase long-chain family member 3
increases expression
EXP
muraglitazar results in increased expression of ACSL3 mRNA
CTD
PMID:21515302
NCBI chr 9:80,115,164...80,164,636
Ensembl chr 9:80,115,112...80,164,627
G
Acsm2
acyl-CoA synthetase medium-chain family member 2
increases expression
EXP
muraglitazar results in increased expression of ACSM2A mRNA
CTD
PMID:21515302
NCBI chr 1:173,916,368...173,955,116
Ensembl chr 1:173,916,368...173,955,116
G
Acsm3
acyl-CoA synthetase medium-chain family member 3
increases expression
EXP
muraglitazar results in increased expression of ACSM3 mRNA
CTD
PMID:21515302
NCBI chr 1:174,133,260...174,159,966
Ensembl chr 1:174,133,288...174,160,184
G
Actn1
actinin, alpha 1
decreases expression
EXP
muraglitazar results in decreased expression of ACTN1 mRNA
CTD
PMID:21515302
NCBI chr 6:98,998,553...99,093,334
Ensembl chr 6:98,998,556...99,093,251
G
Adcy10
adenylate cyclase 10
increases expression
EXP
muraglitazar results in increased expression of ADCY10 mRNA
CTD
PMID:21515302
NCBI chr13:77,747,752...77,833,952
Ensembl chr13:77,768,468...77,833,951
G
Adgre1
adhesion G protein-coupled receptor E1
decreases expression
EXP
muraglitazar results in decreased expression of ADGRE1 mRNA
CTD
PMID:21515302
NCBI chr 9:2,242,476...2,398,000
Ensembl chr 9:2,242,474...2,398,000
G
Adgrg2
adhesion G protein-coupled receptor G2
increases expression
EXP
muraglitazar results in increased expression of ADGRG2 mRNA
CTD
PMID:21515302
NCBI chr X:34,297,402...34,422,590
Ensembl chr X:34,297,402...34,422,609
G
Adh6
alcohol dehydrogenase 6 (class V)
increases expression
EXP
muraglitazar results in increased expression of ADH6 mRNA
CTD
PMID:21515302
NCBI chr 2:226,903,208...226,934,564
Ensembl chr 2:226,903,250...226,934,534
G
Adipoq
adiponectin, C1Q and collagen domain containing
decreases expression
EXP
muraglitazar results in decreased expression of ADIPOQ mRNA
CTD
PMID:21515302
NCBI chr11:77,721,912...77,735,644
Ensembl chr11:77,721,912...77,735,564
G
Adm
adrenomedullin
increases expression
EXP
muraglitazar results in increased expression of ADM mRNA
CTD
PMID:21515302
NCBI chr 1:164,745,484...164,747,655
Ensembl chr 1:164,745,466...164,747,654
G
Adra1b
adrenoceptor alpha 1B
increases expression
EXP
muraglitazar results in increased expression of ADRA1B mRNA
CTD
PMID:21515302
NCBI chr10:28,255,025...28,373,418
Ensembl chr10:28,255,025...28,312,919
G
Adss1
adenylosuccinate synthase 1
increases expression
EXP
muraglitazar results in increased expression of ADSS1 mRNA
CTD
PMID:21515302
NCBI chr 6:131,679,795...131,702,012
Ensembl chr 6:131,679,701...131,701,998
G
Adtrp
androgen-dependent TFPI-regulating protein
increases expression
EXP
muraglitazar results in increased expression of ADTRP mRNA
CTD
PMID:21515302
NCBI chr17:22,907,758...22,993,834
Ensembl chr17:22,930,740...22,993,826
G
Agxt
alanine--glyoxylate aminotransferase
increases expression
EXP
muraglitazar results in increased expression of AGXT mRNA
CTD
PMID:21515302
NCBI chr 9:93,675,384...93,685,337
Ensembl chr 9:93,675,384...93,685,336
G
Aif1
allograft inflammatory factor 1
decreases expression
EXP
muraglitazar results in decreased expression of AIF1 mRNA
CTD
PMID:21515302
NCBI chr20:3,646,784...3,652,670
Ensembl chr20:3,646,777...3,652,668
G
Akr1d1
aldo-keto reductase family 1, member D1
increases expression
EXP
muraglitazar results in increased expression of AKR1D1 mRNA
CTD
PMID:21515302
NCBI chr 4:66,154,246...66,187,505
Ensembl chr 4:66,154,248...66,186,372
G
Alb
albumin
multiple interactions
ISO
[Oleic Acid co-treated with muraglitazar] results in increased expression of ALB mRNA
CTD
PMID:24534255
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
G
Alcam
activated leukocyte cell adhesion molecule
decreases expression
EXP
muraglitazar results in decreased expression of ALCAM mRNA
CTD
PMID:21515302
NCBI chr11:48,336,123...48,536,296
Ensembl chr11:48,336,169...48,537,954
G
Aldh1a1
aldehyde dehydrogenase 1 family, member A1
increases expression
EXP
muraglitazar results in increased expression of ALDH1A1 mRNA
CTD
PMID:21515302
NCBI chr 1:218,000,470...218,152,962
Ensembl chr 1:218,042,127...218,152,961
G
Aldh3b1
aldehyde dehydrogenase 3 family, member B1
decreases expression
EXP
muraglitazar results in decreased expression of ALDH3B1 mRNA
CTD
PMID:21515302
NCBI chr 1:201,145,309...201,162,675
Ensembl chr 1:201,145,309...201,163,921
G
Aldh6a1
aldehyde dehydrogenase 6 family, member A1
increases expression
EXP
muraglitazar results in increased expression of ALDH6A1 mRNA
CTD
PMID:21515302
NCBI chr 6:104,077,975...104,098,636
Ensembl chr 6:104,077,979...104,098,656
G
Aldob
aldolase, fructose-bisphosphate B
decreases expression
EXP
muraglitazar results in decreased expression of ALDOB mRNA
CTD
PMID:21515302
NCBI chr 5:63,889,045...63,902,086
Ensembl chr 5:63,889,046...63,902,116
G
Alpi
alkaline phosphatase, intestinal
decreases expression
EXP
muraglitazar results in decreased expression of ALPI mRNA
CTD
PMID:21515302
NCBI chr 9:87,773,411...87,776,877
Ensembl chr 9:87,773,411...87,776,877
G
Alpl
alkaline phosphatase, biomineralization associated
increases expression
EXP
muraglitazar results in increased expression of ALPL mRNA
CTD
PMID:21515302
NCBI chr 5:149,951,397...150,006,424
Ensembl chr 5:149,951,409...150,006,446
G
Ampd3
adenosine monophosphate deaminase 3
decreases expression
EXP
muraglitazar results in decreased expression of AMPD3 mRNA
CTD
PMID:21515302
NCBI chr 1:164,884,823...164,929,899
Ensembl chr 1:164,885,320...164,929,887
G
Angptl4
angiopoietin-like 4
increases expression
EXP
muraglitazar results in increased expression of ANGPTL4 mRNA
CTD
PMID:21515302
NCBI chr 7:14,550,288...14,557,797
Ensembl chr 7:14,550,311...14,556,519
G
Ankrd1
ankyrin repeat domain 1
decreases expression
EXP
muraglitazar results in decreased expression of ANKRD1 mRNA
CTD
PMID:21515302
NCBI chr 1:233,815,851...233,834,891
Ensembl chr 1:233,815,851...233,834,919
G
Antxr1
ANTXR cell adhesion molecule 1
increases expression
EXP
muraglitazar results in increased expression of ANTXR1 mRNA
CTD
PMID:21515302
NCBI chr 4:119,590,770...119,778,232
Ensembl chr 4:119,590,771...119,778,232
G
Aopep
aminopeptidase O
decreases expression
EXP
muraglitazar results in decreased expression of AOPEP mRNA
CTD
PMID:21515302
NCBI chr17:1,811,281...2,127,316
Ensembl chr17:1,811,980...2,127,331
G
Apaf1
apoptotic peptidase activating factor 1
decreases expression
EXP
muraglitazar results in decreased expression of APAF1 mRNA
CTD
PMID:21515302
NCBI chr 7:25,494,143...25,579,540
Ensembl chr 7:25,494,609...25,579,540
G
Apln
apelin
increases expression
EXP
muraglitazar results in increased expression of APLN mRNA
CTD
PMID:21515302
NCBI chr X:127,180,801...127,213,567
Ensembl chr X:127,203,823...127,213,391
G
Apoc3
apolipoprotein C3
multiple interactions
ISO
[Oleic Acid co-treated with muraglitazar] results in increased expression of APOC3 mRNA
CTD
PMID:24534255
NCBI chr 8:46,531,478...46,533,658
Ensembl chr 8:46,531,478...46,533,583
G
Aqp3
aquaporin 3 (Gill blood group)
increases expression
EXP
muraglitazar results in increased expression of AQP3 mRNA
CTD
PMID:21515302
NCBI chr 5:56,239,200...56,244,718
Ensembl chr 5:56,239,201...56,244,720
G
Aqp7
aquaporin 7
increases expression
EXP
muraglitazar results in increased expression of AQP7 mRNA
CTD
PMID:21515302
NCBI chr 5:56,171,649...56,186,642
Ensembl chr 5:56,172,519...56,186,642
G
Areg
amphiregulin
decreases expression
EXP
muraglitazar results in decreased expression of AREG mRNA
CTD
PMID:21515302
NCBI chr14:16,972,185...16,981,443
Ensembl chr14:16,972,187...16,981,535
G
Arg2
arginase 2
decreases expression
EXP
muraglitazar results in decreased expression of ARG2 mRNA
CTD
PMID:21515302
NCBI chr 6:97,936,002...97,961,379
Ensembl chr 6:97,936,002...97,961,378
G
Arid5a
AT-rich interaction domain 5A
decreases expression
EXP
muraglitazar results in decreased expression of ARID5A mRNA
CTD
PMID:21515302
NCBI chr 9:38,534,612...38,549,467
Ensembl chr 9:38,534,590...38,547,597
G
Asb2
ankyrin repeat and SOCS box-containing 2
increases expression
EXP
muraglitazar results in increased expression of ASB2 mRNA
CTD
PMID:21515302
NCBI chr 6:122,474,754...122,511,014
Ensembl chr 6:122,474,756...122,510,854
G
Asic3
acid sensing ion channel subunit 3
decreases expression
EXP
muraglitazar results in decreased expression of ASIC3 mRNA
CTD
PMID:21515302
NCBI chr 4:10,760,509...10,764,987
Ensembl chr 4:10,760,597...10,764,643
G
Aurkb
aurora kinase B
decreases expression
EXP
muraglitazar results in decreased expression of AURKB mRNA
CTD
PMID:21515302
NCBI chr10:53,744,290...53,750,831
Ensembl chr10:53,745,142...53,750,837
G
Avp
arginine vasopressin
increases expression
EXP
muraglitazar results in increased expression of AVP mRNA
CTD
PMID:21515302
NCBI chr 3:117,793,447...117,805,091
Ensembl chr 3:117,793,457...117,795,425
G
Avpr1a
arginine vasopressin receptor 1A
decreases expression
EXP
muraglitazar results in decreased expression of AVPR1A mRNA
CTD
PMID:21515302
NCBI chr 7:58,114,306...58,118,230
Ensembl chr 7:58,114,284...58,122,215
G
Axin2
axin 2
decreases expression
EXP
muraglitazar results in decreased expression of AXIN2 mRNA
CTD
PMID:21515302
NCBI chr10:93,893,830...93,927,042
Ensembl chr10:93,899,245...93,926,231
G
Bcl2a1
BCL2-related protein A1
decreases expression
EXP
muraglitazar results in decreased expression of BCL2A1 mRNA
CTD
PMID:21515302
NCBI chr 8:89,716,914...89,724,998
Ensembl chr 8:89,716,914...89,724,998
G
Bik
BCL2-interacting killer
decreases expression
EXP
muraglitazar results in decreased expression of BIK mRNA
CTD
PMID:21515302
NCBI chr 7:114,672,277...114,691,296
Ensembl chr 7:114,672,277...114,691,296
G
Bmal2
basic helix-loop-helix ARNT like 2
decreases expression
EXP
muraglitazar results in decreased expression of BMAL2 mRNA
CTD
PMID:21515302
NCBI chr 4:179,699,432...179,747,710
Ensembl chr 4:179,699,502...179,746,949
G
Bmp2
bone morphogenetic protein 2
decreases expression
EXP
muraglitazar results in decreased expression of BMP2 mRNA
CTD
PMID:21515302
NCBI chr 3:120,812,660...120,822,579
Ensembl chr 3:120,812,882...120,821,397
G
Btd
biotinidase
increases expression
EXP
muraglitazar results in increased expression of BTD mRNA
CTD
PMID:21515302
NCBI chr16:6,863,068...6,894,345
Ensembl chr16:6,862,407...6,940,945
G
C1s
complement C1s
decreases expression
EXP
muraglitazar results in decreased expression of C1S mRNA
CTD
PMID:21515302
NCBI chr 4:157,430,249...157,442,438
Ensembl chr 4:157,430,117...157,442,303
G
C4bpb
complement component 4 binding protein, beta
decreases expression
EXP
muraglitazar results in decreased expression of C4BPB mRNA
CTD
PMID:21515302
NCBI chr13:42,120,798...42,131,515
Ensembl chr13:42,120,798...42,131,817
G
C5ar1
complement C5a receptor 1
decreases expression
EXP
muraglitazar results in decreased expression of C5AR1 mRNA
CTD
PMID:21515302
NCBI chr 1:76,948,622...76,959,826
G
C5ar2
complement C5a receptor 2
decreases expression
EXP
muraglitazar results in decreased expression of C5AR2 mRNA
CTD
PMID:21515302
NCBI chr 1:76,930,381...76,945,432
Ensembl chr 1:76,930,383...76,959,517
G
Calcb
calcitonin-related polypeptide, beta
decreases expression
EXP
muraglitazar results in decreased expression of CALCB mRNA
CTD
PMID:21515302
NCBI chr 1:168,965,383...168,970,259
Ensembl chr 1:168,966,465...168,970,125
G
Calhm6
calcium homeostasis modulator family member 6
decreases expression
EXP
muraglitazar results in decreased expression of CALHM6 mRNA
CTD
PMID:21515302
NCBI chr20:26,095,591...26,097,336
Ensembl chr20:26,095,592...26,097,278
G
Cat
catalase
increases expression
EXP
muraglitazar results in increased expression of CAT mRNA
CTD
PMID:21515302
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
G
Catsperd
cation channel sperm associated auxiliary subunit delta
increases expression
EXP
muraglitazar results in increased expression of CATSPERD mRNA
CTD
PMID:21515302
NCBI chr 9:1,459,967...1,498,342
Ensembl chr 9:1,460,001...1,498,344
G
Cbs
cystathionine beta synthase
increases expression
EXP
muraglitazar results in increased expression of CBS mRNA
CTD
PMID:21515302
NCBI chr20:9,708,089...9,732,623
Ensembl chr20:9,708,090...9,732,764
G
Ccl2
C-C motif chemokine ligand 2
decreases expression
EXP
muraglitazar results in decreased expression of CCL2 mRNA
CTD
PMID:21515302
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
G
Ccl20
C-C motif chemokine ligand 20
decreases expression
EXP
muraglitazar results in decreased expression of CCL20 mRNA
CTD
PMID:21515302
NCBI chr 9:84,389,031...84,391,629
Ensembl chr 9:84,388,904...84,391,629
G
Ccl3
C-C motif chemokine ligand 3
decreases expression
EXP
muraglitazar results in decreased expression of CCL3 mRNA
CTD
PMID:21515302
NCBI chr10:68,451,388...68,452,938
Ensembl chr10:68,451,388...68,452,938
G
Ccl4
C-C motif chemokine ligand 4
decreases expression
EXP
muraglitazar results in decreased expression of CCL4 mRNA
CTD
PMID:21515302
NCBI chr10:68,466,394...68,468,229
Ensembl chr10:68,452,052...68,468,231
G
Ccl7
C-C motif chemokine ligand 7
decreases expression
EXP
muraglitazar results in decreased expression of CCL7 mRNA
CTD
PMID:21515302
NCBI chr10:67,016,446...67,018,296
Ensembl chr10:67,016,446...67,018,303
G
Ccl9
C-C motif chemokine ligand 9
decreases expression
EXP
muraglitazar results in decreased expression of CCL6 mRNA
CTD
PMID:21515302
NCBI chr10:68,366,486...68,371,408
Ensembl chr10:68,366,487...68,371,369
G
Ccn2
cellular communication network factor 2
decreases expression
EXP
muraglitazar results in decreased expression of CCN2 mRNA
CTD
PMID:21515302
NCBI chr 1:20,802,199...20,805,315
Ensembl chr 1:20,802,199...20,805,734
G
Cd36
CD36 molecule
increases expression
EXP
muraglitazar results in increased expression of CD36 mRNA
CTD
PMID:21515302
NCBI chr 4:17,317,343...17,410,084
Ensembl chr 4:17,354,466...17,513,903
G
Cd44
CD44 molecule
decreases expression
EXP
muraglitazar results in decreased expression of CD44 mRNA
CTD
PMID:21515302
NCBI chr 3:89,155,850...89,244,615
Ensembl chr 3:89,157,058...89,244,620
G
Cd9
CD9 molecule
decreases expression
EXP
muraglitazar results in decreased expression of CD9 mRNA
CTD
PMID:21515302
NCBI chr 4:158,256,328...158,289,136
Ensembl chr 4:158,256,328...158,289,222
G
Cdc25a
cell division cycle 25A
increases expression
EXP
muraglitazar results in increased expression of CDC25A mRNA
CTD
PMID:21515302
NCBI chr 8:109,864,356...109,882,734
Ensembl chr 8:109,864,478...109,882,701
G
Cdh1
cadherin 1
decreases expression
EXP
muraglitazar results in decreased expression of CDH1 mRNA
CTD
PMID:21515302
NCBI chr19:34,492,371...34,561,775
Ensembl chr19:34,492,371...34,561,775
G
Cebpb
CCAAT/enhancer binding protein beta
increases expression
EXP
muraglitazar results in increased expression of CEBPB mRNA
CTD
PMID:21515302
NCBI chr 3:156,398,035...156,399,466
Ensembl chr 3:156,397,052...156,399,473
G
Cenpu
centromere protein U
decreases expression
EXP
muraglitazar results in decreased expression of CENPU mRNA
CTD
PMID:21515302
NCBI chr16:45,715,821...45,739,038
Ensembl chr16:45,714,294...45,738,823
G
Ces2h
carboxylesterase 2H
increases expression
EXP
muraglitazar results in increased expression of CES2 mRNA
CTD
PMID:21515302
NCBI chr19:32,974,242...32,988,842
Ensembl chr19:32,974,242...32,988,830
G
Cesl1
carboxylesterase-like 1
increases expression
EXP
muraglitazar results in increased expression of CESL1 mRNA
CTD
PMID:21515302
NCBI chr19:22,670,709...23,006,329
Ensembl chr19:22,670,712...22,712,608
G
Cfd
complement factor D
increases expression
EXP
muraglitazar results in increased expression of CFD mRNA
CTD
PMID:21515302
NCBI chr 7:9,813,148...9,814,871
Ensembl chr 7:9,813,150...9,815,053
G
Ch25h
cholesterol 25-hydroxylase
decreases expression
EXP
muraglitazar results in decreased expression of CH25H mRNA
CTD
PMID:21515302
NCBI chr 1:232,014,877...232,016,195
Ensembl chr 1:232,014,880...232,016,195
G
Chchd10
coiled-coil-helix-coiled-coil-helix domain containing 10
increases expression
EXP
muraglitazar results in increased expression of CHCHD10 mRNA
CTD
PMID:21515302
NCBI chr20:12,725,839...12,727,638
Ensembl chr20:12,725,842...12,732,763
G
Chgb
chromogranin B
increases expression
EXP
muraglitazar results in increased expression of CHGB mRNA
CTD
PMID:21515302
NCBI chr 3:120,043,824...120,057,169
Ensembl chr 3:120,043,738...120,057,166
G
Chkb
choline kinase beta
increases expression
EXP
muraglitazar results in increased expression of CHKB mRNA
CTD
PMID:21515302
NCBI chr 7:120,500,960...120,504,359
Ensembl chr 7:120,500,984...120,504,461
G
Chl1
cell adhesion molecule L1-like
decreases expression
EXP
muraglitazar results in decreased expression of CHL1 mRNA
CTD
PMID:21515302
NCBI chr 4:136,291,504...136,505,830
Ensembl chr 4:136,291,463...136,503,265
G
Chpt1
choline phosphotransferase 1
increases expression
EXP
muraglitazar results in increased expression of CHPT1 mRNA
CTD
PMID:21515302
NCBI chr 7:22,866,455...22,915,111
Ensembl chr 7:22,863,027...22,915,103
G
Chrna2
cholinergic receptor nicotinic alpha 2 subunit
increases expression
EXP
muraglitazar results in increased expression of CHRNA2 mRNA
CTD
PMID:21515302
NCBI chr15:40,342,317...40,358,601
Ensembl chr15:40,342,317...40,358,601
G
Chrna6
cholinergic receptor nicotinic alpha 6 subunit
decreases expression
EXP
muraglitazar results in decreased expression of CHRNA6 mRNA
CTD
PMID:21515302
NCBI chr16:64,697,741...64,704,441
Ensembl chr16:64,697,741...64,704,441
G
Chrng
cholinergic receptor nicotinic gamma subunit
decreases expression
EXP
muraglitazar results in decreased expression of CHRNG mRNA
CTD
PMID:21515302
NCBI chr 9:87,878,085...87,884,193
Ensembl chr 9:87,878,085...87,914,482
G
Cited1
Cbp/p300-interacting transactivator with Glu/Asp-rich carboxy-terminal domain 1
decreases expression
EXP
muraglitazar results in decreased expression of CITED1 mRNA
CTD
PMID:21515302
NCBI chr X:67,350,376...67,355,072
Ensembl chr X:67,350,373...67,355,162
G
Cited2
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2
decreases expression
EXP
muraglitazar results in decreased expression of CITED2 mRNA
CTD
PMID:21515302
NCBI chr 1:12,312,426...12,314,869
Ensembl chr 1:12,312,160...12,314,897
G
Cldn1
claudin 1
increases expression
EXP
muraglitazar results in increased expression of CLDN1 mRNA
CTD
PMID:21515302
NCBI chr11:74,421,569...74,436,728
Ensembl chr11:74,421,569...74,436,724
G
Clpx
caseinolytic mitochondrial matrix peptidase chaperone subunit X
increases expression
EXP
muraglitazar results in increased expression of CLPX mRNA
CTD
PMID:21515302
NCBI chr 8:65,805,460...65,845,643
Ensembl chr 8:65,805,511...65,845,082
G
Clstn2
calsyntenin 2
decreases expression
EXP
muraglitazar results in decreased expression of CLSTN2 mRNA
CTD
PMID:21515302
NCBI chr 8:98,020,406...98,637,232
Ensembl chr 8:98,021,666...98,637,731
G
Clxn
calaxin
decreases expression
EXP
muraglitazar results in decreased expression of CLXN mRNA
CTD
PMID:21515302
NCBI chr11:85,977,231...85,996,561
Ensembl chr11:85,983,304...85,996,538
G
Cmbl
carboxymethylenebutenolidase homolog
increases expression
EXP
muraglitazar results in increased expression of CMBL mRNA
CTD
PMID:21515302
NCBI chr 2:82,569,257...82,591,007
Ensembl chr 2:82,571,888...82,591,009
G
Cmklr2
chemerin chemokine-like receptor 2
decreases expression
EXP
muraglitazar results in decreased expression of CMKLR2 mRNA
CTD
PMID:21515302
NCBI chr 9:64,583,310...64,617,883
Ensembl chr 9:64,585,594...64,586,655
G
Cnn1
calponin 1
decreases expression
EXP
muraglitazar results in decreased expression of CNN1 mRNA
CTD
PMID:21515302
NCBI chr 8:20,632,434...20,641,097
Ensembl chr 8:20,632,338...20,641,098
G
Col1a2
collagen type I alpha 2 chain
decreases expression
EXP
muraglitazar results in decreased expression of COL1A2 mRNA
CTD
PMID:21515302
NCBI chr 4:32,563,938...32,598,868
Ensembl chr 4:32,563,381...32,598,867
G
Colq
collagen like tail subunit of asymmetric acetylcholinesterase
increases expression
EXP
muraglitazar results in increased expression of COLQ mRNA
CTD
PMID:21515302
NCBI chr16:6,731,850...6,824,973
Ensembl chr16:6,731,858...6,787,107
G
Cpt1a
carnitine palmitoyltransferase 1A
multiple interactions increases expression
ISO EXP
muraglitazar promotes the reaction [Oleic Acid results in increased expression of CPT1A mRNA] muraglitazar results in increased expression of CPT1A mRNA
CTD
PMID:21515302 PMID:24534255
NCBI chr 1:200,564,634...200,627,059
Ensembl chr 1:200,565,613...200,627,055
G
Cpt1b
carnitine palmitoyltransferase 1B
increases expression
EXP
muraglitazar results in increased expression of CPT1B mRNA
CTD
PMID:21515302
NCBI chr 7:120,491,354...120,500,833
Ensembl chr 7:120,491,354...120,500,404
G
Cpt2
carnitine palmitoyltransferase 2
increases expression multiple interactions
EXP ISO
muraglitazar results in increased expression of CPT2 mRNA [muraglitazar co-treated with Oleic Acid] results in increased expression of CPT2 mRNA
CTD
PMID:21515302 PMID:24534255
NCBI chr 5:122,664,677...122,682,126
Ensembl chr 5:122,664,677...122,682,095
G
Crat
carnitine O-acetyltransferase
increases expression
EXP
muraglitazar results in increased expression of CRAT mRNA
CTD
PMID:21515302
NCBI chr 3:13,675,684...13,689,282
Ensembl chr 3:13,675,684...13,689,255
G
Creb3l3
cAMP responsive element binding protein 3-like 3
increases expression
EXP
muraglitazar results in increased expression of CREB3L3 mRNA
CTD
PMID:21515302
NCBI chr 7:8,622,614...8,631,053
Ensembl chr 7:8,622,614...8,631,048
G
Crot
carnitine O-octanoyltransferase
increases expression
EXP
muraglitazar results in increased expression of CROT mRNA
CTD
PMID:21515302
NCBI chr 4:25,068,270...25,133,111
Ensembl chr 4:25,080,587...25,133,109
G
Csad
cysteine sulfinic acid decarboxylase
increases expression
EXP
muraglitazar results in increased expression of CSAD mRNA
CTD
PMID:21515302
NCBI chr 7:133,308,571...133,337,914
Ensembl chr 7:133,308,574...133,337,615
G
Csf1
colony stimulating factor 1
decreases expression
EXP
muraglitazar results in decreased expression of CSF1 mRNA
CTD
PMID:21515302
NCBI chr 2:195,377,215...195,396,608
Ensembl chr 2:195,377,215...195,411,704
G
Csf2rb
colony stimulating factor 2 receptor subunit beta
decreases expression
EXP
muraglitazar results in decreased expression of CSF2RB mRNA
CTD
PMID:21515302
NCBI chr 7:109,876,919...109,901,589
Ensembl chr 7:109,886,425...109,904,157
G
Csrp3
cysteine and glycine rich protein 3
decreases expression
EXP
muraglitazar results in decreased expression of CSRP3 mRNA
CTD
PMID:21515302
NCBI chr 1:98,528,067...98,546,647
Ensembl chr 1:98,528,068...98,546,653
G
Ctbp2
C-terminal binding protein 2
increases expression
EXP
muraglitazar results in increased expression of CTBP2 mRNA
CTD
PMID:21515302
NCBI chr 1:187,782,064...187,918,115
Ensembl chr 1:187,782,682...187,920,222
G
Cth
cystathionine gamma-lyase
increases expression
EXP
muraglitazar results in increased expression of CTH mRNA
CTD
PMID:21515302
NCBI chr 2:246,975,888...247,002,234
Ensembl chr 2:246,975,894...247,002,234
G
Cxcl1
C-X-C motif chemokine ligand 1
decreases expression
EXP
muraglitazar results in decreased expression of CXCL1 mRNA
CTD
PMID:21515302
NCBI chr14:17,193,364...17,195,143
Ensembl chr14:17,193,365...17,195,215
G
Cxcl10
C-X-C motif chemokine ligand 10
decreases expression
EXP
muraglitazar results in decreased expression of CXCL10 mRNA
CTD
PMID:21515302
NCBI chr14:15,704,772...15,706,969
Ensembl chr14:15,704,758...15,706,975
G
Cxcl11
C-X-C motif chemokine ligand 11
decreases expression
EXP
muraglitazar results in decreased expression of CXCL11 mRNA
CTD
PMID:21515302
NCBI chr14:15,689,432...15,692,207
Ensembl chr14:15,689,424...15,692,271
G
Cxcl12
C-X-C motif chemokine ligand 12
increases expression
EXP
muraglitazar results in increased expression of CXCL12 mRNA
CTD
PMID:21515302
NCBI chr 4:150,388,326...150,401,173
Ensembl chr 4:150,388,325...150,401,168
G
Cxcl2
C-X-C motif chemokine ligand 2
decreases expression
EXP
muraglitazar results in decreased expression of CXCL2 mRNA
CTD
PMID:21515302
NCBI chr14:17,181,030...17,183,075
Ensembl chr14:17,181,062...17,183,075
G
Cyp17a1
cytochrome P450, family 17, subfamily a, polypeptide 1
increases expression
EXP
muraglitazar results in increased expression of CYP17A1 mRNA
CTD
PMID:21515302
NCBI chr 1:245,535,462...245,543,148
Ensembl chr 1:245,535,462...245,541,573
G
Cyp26a1
cytochrome P450, family 26, subfamily a, polypeptide 1
increases expression
EXP
muraglitazar results in increased expression of CYP26A1 mRNA
CTD
PMID:21515302
NCBI chr 1:235,471,368...235,475,204
Ensembl chr 1:235,471,298...235,475,204
G
Cyp2b2
cytochrome P450, family 2, subfamily b, polypeptide 2
increases expression
EXP
muraglitazar results in increased expression of CYP2B2 mRNA
CTD
PMID:21515302
NCBI chr 1:81,594,534...81,608,567
Ensembl chr 1:81,594,555...81,608,566
G
Cyp2j4
cytochrome P450, family 2, subfamily j, polypeptide 4
increases expression
EXP
muraglitazar results in increased expression of CYP2J4 mRNA
CTD
PMID:21515302
NCBI chr 5:111,179,981...111,207,490
Ensembl chr 5:111,178,703...111,244,794
G
Cyp3a23-3a1
cytochrome P450, family 3, subfamily a, polypeptide 23-polypeptide 1
increases expression
EXP
muraglitazar results in increased expression of CYP3A23-3A1 mRNA
CTD
PMID:21515302
NCBI chr12:9,256,159...9,285,020
Ensembl chr12:9,254,475...9,285,030 Ensembl chr12:9,254,475...9,285,030
G
Cyp3a62
cytochrome P450, family 3, subfamily a, polypeptide 62
decreases expression
EXP
muraglitazar results in decreased expression of CYP3A62 mRNA
CTD
PMID:21515302
NCBI chr12:16,397,998...16,433,833
Ensembl chr12:16,397,998...16,433,833
G
Cyp4a1
cytochrome P450, family 4, subfamily a, polypeptide 1
increases expression
EXP
muraglitazar results in increased expression of CYP4A1 mRNA
CTD
PMID:21515302
NCBI chr 5:129,123,323...129,137,464
Ensembl chr 5:129,123,336...129,137,464
G
Cyp4a2
cytochrome P450, family 4, subfamily a, polypeptide 2
increases expression
EXP
muraglitazar results in increased expression of CYP4A2 mRNA
CTD
PMID:21515302
NCBI chr 5:128,922,355...128,934,188
Ensembl chr 5:128,923,615...128,934,165
G
Cyp4a3
cytochrome P450, family 4, subfamily a, polypeptide 3
increases expression
EXP
muraglitazar results in increased expression of CYP4A3 mRNA
CTD
PMID:21515302
NCBI chr 5:129,097,571...129,115,488
Ensembl chr 5:129,097,926...129,115,463
G
Cyp4a8
cytochrome P450, family 4, subfamily a, polypeptide 8
increases expression
EXP
muraglitazar results in increased expression of CYP4A8 mRNA
CTD
PMID:21515302
NCBI chr 5:128,702,130...128,733,476
Ensembl chr 5:128,702,131...128,733,476
G
Cyp4b1
cytochrome P450, family 4, subfamily b, polypeptide 1
increases expression
EXP
muraglitazar results in increased expression of CYP4B1 mRNA
CTD
PMID:21515302
NCBI chr 5:129,139,019...129,176,860
Ensembl chr 5:129,139,038...129,156,348
G
Cyp4f5
cytochrome P450, family 4, subfamily f, polypeptide 5
decreases expression
EXP
muraglitazar results in decreased expression of CYP4F5 mRNA
CTD
PMID:21515302
NCBI chr 7:11,544,040...11,558,982
Ensembl chr 7:11,544,082...11,558,978
G
Cyp7a1
cytochrome P450 family 7 subfamily A member 1
increases expression
EXP
muraglitazar results in increased expression of CYP7A1 mRNA
CTD
PMID:21515302
NCBI chr 5:19,376,979...19,386,676
Ensembl chr 5:19,376,974...19,386,688
G
Cyp8b1
cytochrome P450 family 8 subfamily B member 1
increases expression
EXP
muraglitazar results in increased expression of CYP8B1 mRNA
CTD
PMID:21515302
NCBI chr 8:121,578,123...121,580,093
Ensembl chr 8:121,557,062...121,580,166
G
Dclk1
doublecortin-like kinase 1
decreases expression
EXP
muraglitazar results in decreased expression of DCLK1 mRNA
CTD
PMID:21515302
NCBI chr 2:139,417,234...139,710,956
Ensembl chr 2:139,417,163...139,710,956
G
Ddit4
DNA-damage-inducible transcript 4
increases expression
EXP
muraglitazar results in increased expression of DDIT4 mRNA
CTD
PMID:21515302
NCBI chr20:27,891,989...27,894,088
Ensembl chr20:27,891,998...27,894,105
G
Decr1
2,4-dienoyl-CoA reductase 1
increases expression
EXP
muraglitazar results in increased expression of DECR1 mRNA
CTD
PMID:21515302
NCBI chr 5:29,411,172...29,439,054
Ensembl chr 5:29,411,172...29,439,018
G
Decr2
2,4-dienoyl-CoA reductase 2
increases expression
EXP
muraglitazar results in increased expression of DECR2 mRNA
CTD
PMID:21515302
NCBI chr10:15,104,907...15,113,281
Ensembl chr10:15,002,926...15,118,479
G
Defb1
defensin beta 1
increases expression
EXP
muraglitazar results in increased expression of DEFB1 mRNA
CTD
PMID:21515302
NCBI chr16:70,298,862...70,313,604
Ensembl chr16:70,298,863...70,313,604
G
Dhodh
dihydroorotate dehydrogenase (quinone)
increases expression
EXP
muraglitazar results in increased expression of DHODH mRNA
CTD
PMID:21515302
NCBI chr19:37,551,858...37,573,327
Ensembl chr19:37,558,177...37,591,654
G
Dhrs3
dehydrogenase/reductase 3
increases expression
EXP
muraglitazar results in increased expression of DHRS3 mRNA
CTD
PMID:21515302
NCBI chr 5:156,747,939...156,782,420
Ensembl chr 5:156,747,962...156,782,417
G
Dhrs4
dehydrogenase/reductase 4
increases expression
EXP
muraglitazar results in increased expression of DHRS4 mRNA
CTD
PMID:21515302
NCBI chr15:28,966,544...28,978,135
Ensembl chr15:28,966,553...28,978,127
G
Dipk2a
divergent protein kinase domain 2A
increases expression
EXP
muraglitazar results in increased expression of DIPK2A mRNA
CTD
PMID:21515302
NCBI chr 8:95,070,695...95,089,815
Ensembl chr 8:95,030,279...95,089,815
G
Dnajb7
DnaJ heat shock protein family (Hsp40) member B7
decreases expression
EXP
muraglitazar results in decreased expression of DNAJB7 mRNA
CTD
PMID:21515302
NCBI chr 7:112,932,736...112,934,050
Ensembl chr 7:112,932,616...112,945,537
G
Dnajc5g
DnaJ heat shock protein family (Hsp40) member C5 gamma
decreases expression
EXP
muraglitazar results in decreased expression of DNAJC5G mRNA
CTD
PMID:21515302
NCBI chr 6:25,260,087...25,264,251
Ensembl chr 6:25,260,088...25,264,152
G
Dnase1l3
deoxyribonuclease 1L3
increases expression
EXP
muraglitazar results in increased expression of DNASE1L3 mRNA
CTD
PMID:21515302
NCBI chr15:16,922,335...16,948,322
Ensembl chr15:16,922,335...16,948,317
G
Dusp6
dual specificity phosphatase 6
decreases expression
EXP
muraglitazar results in decreased expression of DUSP6 mRNA
CTD
PMID:21515302
NCBI chr 7:34,092,848...34,097,186
Ensembl chr 7:34,092,943...34,097,185
G
Ech1
enoyl-CoA hydratase 1
multiple interactions increases expression
ISO EXP
[Oleic Acid co-treated with muraglitazar] results in increased expression of ECH1 mRNA muraglitazar results in increased expression of ECH1 mRNA
CTD
PMID:21515302 PMID:24534255
NCBI chr 1:84,114,494...84,120,788
Ensembl chr 1:84,112,751...84,120,795
G
Eci1
enoyl-CoA delta isomerase 1
increases expression
EXP
muraglitazar results in increased expression of ECI1 mRNA
CTD
PMID:21515302
NCBI chr10:13,456,715...13,470,061
Ensembl chr10:13,456,563...13,470,061
G
Eci2
enoyl-CoA delta isomerase 2
increases expression
EXP
muraglitazar results in increased expression of ECI2 mRNA
CTD
PMID:21515302
NCBI chr17:29,850,884...29,886,781
Ensembl chr17:29,870,391...29,886,781
G
Egln1
egl-9 family hypoxia-inducible factor 1
increases expression
EXP
muraglitazar results in increased expression of EGLN1 mRNA
CTD
PMID:21515302
NCBI chr19:52,867,900...52,907,308
Ensembl chr19:52,869,486...52,907,777
G
Egr1
early growth response 1
decreases expression
EXP
muraglitazar results in decreased expression of EGR1 mRNA
CTD
PMID:21515302
NCBI chr18:26,462,967...26,466,766
Ensembl chr18:26,462,981...26,466,766
G
Ehhadh
enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase
increases expression
EXP
muraglitazar results in increased expression of EHHADH mRNA
CTD
PMID:21515302
NCBI chr11:79,241,927...79,275,173
Ensembl chr11:79,241,938...79,275,188
G
Elovl6
ELOVL fatty acid elongase 6
increases expression
EXP
muraglitazar results in increased expression of ELOVL6 mRNA
CTD
PMID:21515302
NCBI chr 2:218,063,682...218,174,767
Ensembl chr 2:218,063,804...218,171,186
G
Ephx2
epoxide hydrolase 2
increases expression
EXP
muraglitazar results in increased expression of EPHX2 mRNA
CTD
PMID:21515302
NCBI chr15:40,289,901...40,327,632
Ensembl chr15:40,289,902...40,327,615
G
Erich6
glutamate-rich 6
decreases expression
EXP
muraglitazar results in decreased expression of ERICH6 mRNA
CTD
PMID:21515302
NCBI chr 2:142,851,905...142,878,010
Ensembl chr 2:142,851,905...142,884,320
G
Etfdh
electron transfer flavoprotein dehydrogenase
increases expression
EXP
muraglitazar results in increased expression of ETFDH mRNA
CTD
PMID:21515302
NCBI chr 2:164,740,547...164,762,754
Ensembl chr 2:164,729,749...164,762,745
G
F5
coagulation factor V
decreases expression
EXP
muraglitazar results in decreased expression of F5 mRNA
CTD
PMID:21515302
NCBI chr13:76,513,509...76,583,106
Ensembl chr13:76,513,255...76,582,317
G
Fabp1
fatty acid binding protein 1
increases expression
EXP
muraglitazar results in increased expression of FABP1 mRNA
CTD
PMID:21515302
NCBI chr 4:103,191,015...103,194,791
Ensembl chr 4:103,191,006...103,194,788
G
Fabp4
fatty acid binding protein 4
increases expression
EXP
muraglitazar results in increased expression of FABP4 mRNA
CTD
PMID:21515302
NCBI chr 2:91,580,879...91,585,567
Ensembl chr 2:91,580,885...91,585,578
G
Fahd1
fumarylacetoacetate hydrolase domain containing 1
increases expression
EXP
muraglitazar results in increased expression of FAHD1 mRNA
CTD
PMID:21515302
NCBI chr10:13,873,539...13,874,978
Ensembl chr10:13,873,527...13,875,012
G
Fam13a
family with sequence similarity 13, member A
increases expression
EXP
muraglitazar results in increased expression of FAM13A mRNA
CTD
PMID:21515302
NCBI chr 4:88,056,521...88,155,782
Ensembl chr 4:88,058,403...88,155,860
G
Fam149a
family with sequence similarity 149, member A
decreases expression
EXP
muraglitazar results in decreased expression of FAM149A mRNA
CTD
PMID:21515302
NCBI chr16:46,855,377...46,914,553
Ensembl chr16:46,854,635...46,912,066
G
Fam162a
family with sequence similarity 162, member A
increases expression
EXP
muraglitazar results in increased expression of FAM162A mRNA
CTD
PMID:21515302
NCBI chr11:64,680,978...64,709,865
Ensembl chr11:64,680,323...64,711,239
G
Fbp1
fructose-bisphosphatase 1
increases expression
EXP
muraglitazar results in increased expression of FBP1 mRNA
CTD
PMID:21515302
NCBI chr17:2,207,271...2,230,076
Ensembl chr17:2,208,031...2,230,071
G
Fbp2
fructose-bisphosphatase 2
increases expression
EXP
muraglitazar results in increased expression of FBP2 mRNA
CTD
PMID:21515302
NCBI chr17:2,236,088...2,253,702
Ensembl chr17:2,236,336...2,253,698
G
Fbxo32
F-box protein 32
decreases expression
EXP
muraglitazar results in decreased expression of FBXO32 mRNA
CTD
PMID:21515302
NCBI chr 7:89,731,428...89,764,997
Ensembl chr 7:89,730,232...89,765,436
G
Fbxo9
f-box protein 9
increases expression
EXP
muraglitazar results in increased expression of FBXO9 mRNA
CTD
PMID:21515302
NCBI chr 8:78,958,482...78,984,015
Ensembl chr 8:78,958,483...78,983,949
G
Fgf21
fibroblast growth factor 21
increases expression
EXP
muraglitazar results in increased expression of FGF21 mRNA
CTD
PMID:21515302
NCBI chr 1:96,083,360...96,084,911
Ensembl chr 1:96,083,441...96,090,454
G
Fgr
FGR proto-oncogene, Src family tyrosine kinase
increases expression
EXP
muraglitazar results in increased expression of FGR mRNA
CTD
PMID:21515302
NCBI chr 5:145,189,814...145,219,571
Ensembl chr 5:145,189,841...145,217,326
G
Fibin
fin bud initiation factor homolog
increases expression
EXP
muraglitazar results in increased expression of FIBIN mRNA
CTD
PMID:21515302
NCBI chr 3:96,942,405...96,944,676
Ensembl chr 3:96,942,406...96,944,676
G
Fignl1
fidgetin-like 1
increases expression
EXP
muraglitazar results in increased expression of FIGNL1 mRNA
CTD
PMID:21515302
NCBI chr14:86,368,670...86,381,728
Ensembl chr14:86,368,675...86,377,455
G
Fmo1
flavin containing dimethylaniline monoxygenase 1
decreases expression
EXP
muraglitazar results in decreased expression of FMO1 mRNA
CTD
PMID:21515302
NCBI chr13:75,182,184...75,214,439
Ensembl chr13:75,182,176...75,214,647
G
Fosl1
FOS like 1, AP-1 transcription factor subunit
decreases expression
EXP
muraglitazar results in decreased expression of FOSL1 mRNA
CTD
PMID:21515302
NCBI chr 1:202,754,549...202,763,057
Ensembl chr 1:202,754,529...202,764,930
G
Foxi2
forkhead box I2
increases expression
EXP
muraglitazar results in increased expression of FOXI2 mRNA
CTD
PMID:21515302
NCBI chr 1:190,222,857...190,226,657
Ensembl chr 1:190,222,703...190,226,433
G
Foxj1
forkhead box J1
decreases expression
EXP
muraglitazar results in decreased expression of FOXJ1 mRNA
CTD
PMID:21515302
NCBI chr10:101,566,299...101,570,370
Ensembl chr10:101,566,304...101,570,237
G
Frmd4b
FERM domain containing 4B
decreases expression
EXP
muraglitazar results in decreased expression of FRMD4B mRNA
CTD
PMID:21515302
NCBI chr 4:129,895,401...130,222,070
Ensembl chr 4:129,895,708...130,084,197
G
Frmd6
FERM domain containing 6
decreases expression
EXP
muraglitazar results in decreased expression of FRMD6 mRNA
CTD
PMID:21515302
NCBI chr 6:89,345,983...89,419,579
Ensembl chr 6:89,346,035...89,419,579
G
Ftcd
formimidoyltransferase cyclodeaminase
increases expression
EXP
muraglitazar results in increased expression of FTCD mRNA
CTD
PMID:21515302
NCBI chr20:12,055,203...12,068,717
Ensembl chr20:12,055,208...12,068,735
G
Fut1
fucosyltransferase 1
increases expression
EXP
muraglitazar results in increased expression of FUT1 mRNA
CTD
PMID:21515302
NCBI chr 1:96,086,934...96,090,352
Ensembl chr 1:96,086,635...96,090,616
G
Fxyd5
FXYD domain-containing ion transport regulator 5
decreases expression
EXP
muraglitazar results in decreased expression of FXYD5 mRNA
CTD
PMID:21515302
NCBI chr 1:86,267,937...86,277,329
Ensembl chr 1:86,267,406...86,277,519
G
G0s2
G0/G1switch 2
increases expression
EXP
muraglitazar results in increased expression of G0S2 mRNA
CTD
PMID:21515302
NCBI chr13:104,806,351...104,807,263
Ensembl chr13:104,806,156...104,807,451
G
G6pc1
glucose-6-phosphatase catalytic subunit 1
increases expression
EXP
muraglitazar results in increased expression of G6PC1 mRNA
CTD
PMID:21515302
NCBI chr10:86,307,400...86,318,766
Ensembl chr10:86,257,668...86,333,804
G
Gale
UDP-galactose-4-epimerase
increases expression
EXP
muraglitazar results in increased expression of GALE mRNA
CTD
PMID:21515302
NCBI chr 5:148,193,886...148,198,392
Ensembl chr 5:148,194,791...148,198,388
G
Galnt16
polypeptide N-acetylgalactosaminyltransferase 16
decreases expression
EXP
muraglitazar results in decreased expression of GALNT16 mRNA
CTD
PMID:21515302
NCBI chr 6:100,168,943...100,250,718
Ensembl chr 6:100,170,306...100,250,705
G
Gckr
glucokinase regulator
increases expression
EXP
muraglitazar results in increased expression of GCKR mRNA
CTD
PMID:21515302
NCBI chr 6:25,044,592...25,075,834
Ensembl chr 6:25,045,100...25,075,654
G
Gfra1
GDNF family receptor alpha 1
decreases expression
EXP
muraglitazar results in decreased expression of GFRA1 mRNA
CTD
PMID:21515302
NCBI chr 1:257,315,682...257,552,004
Ensembl chr 1:257,321,742...257,551,473
G
Gjb3
gap junction protein, beta 3
decreases expression
EXP
muraglitazar results in decreased expression of GJB3 mRNA
CTD
PMID:21515302
NCBI chr 5:139,649,227...139,654,970
Ensembl chr 5:139,649,195...139,654,980
G
Gk
glycerol kinase
increases expression
EXP
muraglitazar results in increased expression of GK mRNA
CTD
PMID:21515302
NCBI chr X:50,162,089...50,238,707
Ensembl chr X:50,163,123...50,238,631
G
Glrx
glutaredoxin
increases expression
EXP
muraglitazar results in increased expression of GLRX mRNA
CTD
PMID:21515302
NCBI chr 2:5,341,873...5,351,686
Ensembl chr 2:5,341,885...5,351,680
G
Gnat3
G protein subunit alpha transducin 3
increases expression
EXP
muraglitazar results in increased expression of GNAT3 mRNA
CTD
PMID:21515302
NCBI chr 4:17,162,500...17,212,283
Ensembl chr 4:17,162,490...17,212,283
G
Got1l1
glutamic-oxaloacetic transaminase 1-like 1
decreases expression
EXP
muraglitazar results in decreased expression of GOT1L1 mRNA
CTD
PMID:21515302
NCBI chr16:64,860,308...64,873,656
Ensembl chr16:64,860,704...64,866,162
G
Gpam
glycerol-3-phosphate acyltransferase, mitochondrial
increases expression
EXP
muraglitazar results in increased expression of GPAM mRNA
CTD
PMID:21515302
NCBI chr 1:254,106,323...254,170,755
Ensembl chr 1:254,106,331...254,142,639
G
Gpc3
glypican 3
increases expression
EXP
muraglitazar results in increased expression of GPC3 mRNA
CTD
PMID:21515302
NCBI chr X:131,868,986...132,236,824
Ensembl chr X:131,868,990...132,236,798
G
Gpd2
glycerol-3-phosphate dehydrogenase 2
increases expression
EXP
muraglitazar results in increased expression of GPD2 mRNA
CTD
PMID:21515302
NCBI chr 3:41,800,552...41,937,729
Ensembl chr 3:41,801,930...41,936,901
G
Gpr18
G protein-coupled receptor 18
decreases expression
EXP
muraglitazar results in decreased expression of GPR18 mRNA
CTD
PMID:21515302
NCBI chr15:98,997,427...99,001,177
Ensembl chr15:98,997,259...99,001,470
G
Gpr183
G protein-coupled receptor 183
decreases expression
EXP
muraglitazar results in decreased expression of GPR183 mRNA
CTD
PMID:21515302
NCBI chr15:99,037,764...99,050,550
Ensembl chr15:99,036,367...99,050,559
G
Gpt
glutamic--pyruvic transaminase
increases expression
EXP
muraglitazar results in increased expression of GPT mRNA
CTD
PMID:21515302
NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494
G
Gsn
gelsolin
increases expression
EXP
muraglitazar results in increased expression of GSN mRNA
CTD
PMID:21515302
NCBI chr 3:18,585,166...18,638,404
Ensembl chr 3:18,585,172...18,638,402
G
Gstp1
glutathione S-transferase pi 1
decreases expression
EXP
muraglitazar results in decreased expression of GSTP1 mRNA
CTD
PMID:21515302
NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
G
Gys1
glycogen synthase 1
increases expression
EXP
muraglitazar results in increased expression of GYS1 mRNA
CTD
PMID:21515302
NCBI chr 1:95,915,443...95,935,292
Ensembl chr 1:95,915,443...95,935,292
G
Gys2
glycogen synthase 2
increases expression
EXP
muraglitazar results in increased expression of GYS2 mRNA
CTD
PMID:21515302
NCBI chr 4:175,365,054...175,406,228
Ensembl chr 4:175,365,054...175,406,228
G
H1f0
H1.0 linker histone
increases expression
EXP
muraglitazar results in increased expression of H1F0 mRNA
CTD
PMID:21515302
NCBI chr 7:110,592,834...110,594,694
Ensembl chr 7:110,592,208...110,594,694
G
Hacl1
2-hydroxyacyl-CoA lyase 1
increases expression
EXP
muraglitazar results in increased expression of HACL1 mRNA
CTD
PMID:21515302
NCBI chr16:6,826,881...6,863,027
Ensembl chr16:6,824,906...6,863,027
G
Hadh
hydroxyacyl-CoA dehydrogenase
increases expression
EXP
muraglitazar results in increased expression of HADH mRNA
CTD
PMID:21515302
NCBI chr 2:219,787,935...219,830,335
Ensembl chr 2:219,787,927...219,830,353
G
Hadha
hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha
increases expression
EXP
muraglitazar results in increased expression of HADHA mRNA
CTD
PMID:21515302
NCBI chr 6:26,187,969...26,227,605
Ensembl chr 6:26,187,956...26,227,869
G
Hadhb
hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit beta
increases expression
EXP
muraglitazar results in increased expression of HADHB mRNA
CTD
PMID:21515302
NCBI chr 6:26,153,572...26,187,668
Ensembl chr 6:26,153,578...26,184,869
G
Hamp
hepcidin antimicrobial peptide
decreases expression
EXP
muraglitazar results in decreased expression of HAMP mRNA
CTD
PMID:21515302
NCBI chr 1:86,170,926...86,172,865
Ensembl chr 1:86,170,901...86,172,891
G
Hapln2
hyaluronan and proteoglycan link protein 2
decreases expression
EXP
muraglitazar results in decreased expression of HAPLN2 mRNA
CTD
PMID:21515302
NCBI chr 2:173,488,909...173,496,824
Ensembl chr 2:173,491,160...173,496,588
G
Hbegf
heparin-binding EGF-like growth factor
decreases expression
EXP
muraglitazar results in decreased expression of HBEGF mRNA
CTD
PMID:21515302
NCBI chr18:28,106,284...28,116,167
Ensembl chr18:28,105,760...28,116,441
G
Hcar2
hydroxycarboxylic acid receptor 2
decreases expression
EXP
muraglitazar results in decreased expression of HCAR2 mRNA
CTD
PMID:21515302
NCBI chr12:32,726,252...32,728,238
Ensembl chr12:32,726,184...32,728,504
G
Hdac7
histone deacetylase 7
decreases expression
EXP
muraglitazar results in decreased expression of HDAC7 mRNA
CTD
PMID:21515302
NCBI chr 7:128,923,918...128,961,926
Ensembl chr 7:128,923,920...128,962,072
G
Hibch
3-hydroxyisobutyryl-CoA hydrolase
increases expression
EXP
muraglitazar results in increased expression of HIBCH mRNA
CTD
PMID:21515302
NCBI chr 9:48,590,097...48,669,896
Ensembl chr 9:48,590,099...48,669,824
G
Hmgcs2
3-hydroxy-3-methylglutaryl-CoA synthase 2
increases expression
EXP
muraglitazar results in increased expression of HMGCS2 mRNA
CTD
PMID:21515302
NCBI chr 2:185,875,609...185,903,505
Ensembl chr 2:185,875,616...185,902,130
G
Hsd17b2
hydroxysteroid (17-beta) dehydrogenase 2
increases expression
EXP
muraglitazar results in increased expression of HSD17B2 mRNA
CTD
PMID:21515302
NCBI chr19:45,753,576...45,825,203
Ensembl chr19:45,753,574...45,825,202
G
Hsd17b4
hydroxysteroid (17-beta) dehydrogenase 4
increases expression
EXP
muraglitazar results in increased expression of HSD17B4 mRNA
CTD
PMID:21515302
NCBI chr18:43,328,903...43,417,950
Ensembl chr18:43,328,824...43,417,952
G
Hsd3b1
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1
decreases expression
EXP
muraglitazar results in decreased expression of HSD3B1 mRNA
CTD
PMID:21515302
NCBI chr 2:186,169,864...186,175,984
Ensembl chr 2:186,169,863...186,175,999
G
Hsdl2
hydroxysteroid dehydrogenase like 2
increases expression
EXP
muraglitazar results in increased expression of HSDL2 mRNA
CTD
PMID:21515302
NCBI chr 5:74,443,933...74,479,104
Ensembl chr 5:74,443,872...74,479,839
G
Hspd1-ps13
heat shock protein family D (Hsp60) member 1, pseudogene 13
increases expression
EXP
muraglitazar results in increased expression of HSPD1-PS13 mRNA
CTD
PMID:21515302
NCBI chr 9:46,991,457...46,996,798
G
Hspd1-ps6
heat shock protein family D (Hsp60) member 1, pseudogene 6
increases expression
EXP
muraglitazar results in increased expression of HSPD1-PS6 mRNA
CTD
PMID:21515302
NCBI chr20:31,367,312...31,370,199
G
Hspd1-ps7
heat shock protein family D (Hsp60) member 1, pseudogene 7
increases expression
EXP
muraglitazar results in increased expression of HSPD1-PS7 mRNA
CTD
PMID:21515302
NCBI chr 1:103,645,663...103,648,170
G
Icam1
intercellular adhesion molecule 1
decreases expression
EXP
muraglitazar results in decreased expression of ICAM1 mRNA
CTD
PMID:21515302
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
G
Id1
inhibitor of DNA binding 1
increases expression
EXP
muraglitazar results in increased expression of ID1 mRNA
CTD
PMID:21515302
NCBI chr 3:141,210,666...141,212,420
Ensembl chr 3:141,211,267...141,212,419
G
Ier5l
immediate early response 5-like
increases expression
EXP
muraglitazar results in increased expression of IER5L mRNA
CTD
PMID:21515302
NCBI chr 3:13,744,056...13,745,647
Ensembl chr 3:13,744,078...13,745,647
G
Igfbp3
insulin-like growth factor binding protein 3
increases expression
EXP
muraglitazar results in increased expression of IGFBP3 mRNA
CTD
PMID:21515302
NCBI chr14:82,056,347...82,064,083
Ensembl chr14:82,056,347...82,064,083
G
Il18rap
interleukin 18 receptor accessory protein
decreases expression
EXP
muraglitazar results in decreased expression of IL18RAP mRNA
CTD
PMID:21515302
NCBI chr 9:42,768,112...42,800,964
Ensembl chr 9:42,768,220...42,800,959
G
Il1b
interleukin 1 beta
decreases expression
EXP
muraglitazar results in decreased expression of IL1B mRNA
CTD
PMID:21515302
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il1r1
interleukin 1 receptor type 1
decreases expression
EXP
muraglitazar results in decreased expression of IL1R1 mRNA
CTD
PMID:21515302
NCBI chr 9:42,504,917...42,580,958
Ensembl chr 9:42,504,735...42,579,937
G
Il1r2
interleukin 1 receptor type 2
decreases expression
EXP
muraglitazar results in decreased expression of IL1R2 mRNA
CTD
PMID:21515302
NCBI chr 9:42,384,280...42,424,726
Ensembl chr 9:42,384,433...42,424,725
G
Il1rl1
interleukin 1 receptor-like 1
decreases expression
EXP
muraglitazar results in decreased expression of IL1RL1 mRNA
CTD
PMID:21515302
NCBI chr 9:42,661,694...42,727,266
Ensembl chr 9:42,697,192...42,727,256
G
Il33
interleukin 33
decreases expression
EXP
muraglitazar results in decreased expression of IL33 mRNA
CTD
PMID:21515302
NCBI chr 1:227,701,964...227,736,374
Ensembl chr 1:227,721,435...227,736,373
G
Impa2
inositol monophosphatase 2
increases expression
EXP
muraglitazar results in increased expression of IMPA2 mRNA
CTD
PMID:21515302
NCBI chr18:60,834,206...60,867,575
Ensembl chr18:60,834,246...60,865,641
G
Inhbc
inhibin subunit beta C
increases expression
EXP
muraglitazar results in increased expression of INHBC mRNA
CTD
PMID:21515302
NCBI chr 7:63,184,141...63,197,630
Ensembl chr 7:63,184,142...63,197,630
G
Isl1
ISL LIM homeobox 1
decreases expression
EXP
muraglitazar results in decreased expression of ISL1 mRNA
CTD
PMID:21515302
NCBI chr 2:48,079,412...48,090,704
Ensembl chr 2:48,080,522...48,095,584
G
Itga2
integrin subunit alpha 2
decreases expression
EXP
muraglitazar results in decreased expression of ITGA2 mRNA
CTD
PMID:21515302
NCBI chr 2:46,520,345...46,621,487
Ensembl chr 2:46,523,948...46,621,481
G
Jag2
jagged canonical Notch ligand 2
decreases expression
EXP
muraglitazar results in decreased expression of JAG2 mRNA
CTD
PMID:21515302
NCBI chr 6:131,983,059...132,005,665
Ensembl chr 6:131,983,056...132,005,818
G
Junb
JunB proto-oncogene, AP-1 transcription factor subunit
decreases expression
EXP
muraglitazar results in decreased expression of JUNB mRNA
CTD
PMID:21515302
NCBI chr19:23,176,265...23,178,049
Ensembl chr19:23,176,294...23,178,035
G
Kcng1
potassium voltage-gated channel modifier subfamily G member 1
decreases expression
EXP
muraglitazar results in decreased expression of KCNG1 mRNA
CTD
PMID:21515302
NCBI chr 3:156,960,717...156,992,877
Ensembl chr 3:156,973,156...156,992,635
G
Kcng3
potassium voltage-gated channel modifier subfamily G member 3
decreases expression
EXP
muraglitazar results in decreased expression of KCNG3 mRNA
CTD
PMID:21515302
NCBI chr 6:11,051,311...11,099,264
Ensembl chr 6:11,051,134...11,099,264
G
Kcnj4
potassium inwardly-rectifying channel, subfamily J, member 4
decreases expression
EXP
muraglitazar results in decreased expression of KCNJ4 mRNA
CTD
PMID:21515302
NCBI chr 7:111,047,097...111,074,151
Ensembl chr 7:111,047,094...111,074,151
G
Kcnj8
potassium inwardly-rectifying channel, subfamily J, member 8
increases expression
EXP
muraglitazar results in increased expression of KCNJ8 mRNA
CTD
PMID:21515302
NCBI chr 4:175,508,908...175,515,829
Ensembl chr 4:175,508,912...175,515,603
G
Kcnk2
potassium two pore domain channel subfamily K member 2
increases expression
EXP
muraglitazar results in increased expression of KCNK2 mRNA
CTD
PMID:21515302
NCBI chr13:100,766,101...100,963,435
Ensembl chr13:100,766,113...100,963,435
G
Kcns3
potassium voltage-gated channel, modifier subfamily S, member 3
decreases expression
EXP
muraglitazar results in decreased expression of KCNS3 mRNA
CTD
PMID:21515302
NCBI chr 6:33,808,314...33,865,018
Ensembl chr 6:33,808,216...33,865,125
G
Kif12
kinesin family member 12
decreases expression
EXP
muraglitazar results in decreased expression of KIF12 mRNA
CTD
PMID:21515302
NCBI chr 5:76,596,204...76,603,261
Ensembl chr 5:76,596,208...76,602,843
G
Klf15
KLF transcription factor 15
increases expression
EXP
muraglitazar results in increased expression of KLF15 mRNA
CTD
PMID:21515302
NCBI chr 4:122,965,718...122,978,403
Ensembl chr 4:122,965,807...122,978,374
G
Klk1c6
kallikrein 1-related peptidase C6
decreases expression
EXP
muraglitazar results in decreased expression of KLK1C6 mRNA
CTD
PMID:21515302
NCBI chr 1:94,467,626...94,475,842
Ensembl chr 1:94,467,672...94,475,806
G
Klrb1a
killer cell lectin like receptor B1A
decreases expression
EXP
muraglitazar results in decreased expression of KLRB1A mRNA
CTD
PMID:21515302
NCBI chr 4:161,890,577...161,904,050
Ensembl chr 4:161,890,577...161,961,675
G
Kmo
kynurenine 3-monooxygenase
decreases expression
EXP
muraglitazar results in decreased expression of KMO mRNA
CTD
PMID:21515302
NCBI chr13:87,557,080...87,589,334
Ensembl chr13:87,557,286...87,588,881
G
Krt20
keratin 20
decreases expression
EXP
muraglitazar results in decreased expression of KRT20 mRNA
CTD
PMID:21515302
NCBI chr10:84,384,790...84,394,125
Ensembl chr10:84,384,802...84,394,107
G
Lactb2
lactamase, beta 2
increases expression
EXP
muraglitazar results in increased expression of LACTB2 mRNA
CTD
PMID:21515302
NCBI chr 5:5,569,080...5,591,843
Ensembl chr 5:5,569,067...5,596,429
G
Lcn2
lipocalin 2
decreases expression
EXP
muraglitazar results in decreased expression of LCN2 mRNA
CTD
PMID:21515302
NCBI chr 3:15,680,688...15,684,033
Ensembl chr 3:15,680,687...15,684,095
G
Leap2
liver enriched antimicrobial peptide 2
decreases expression
EXP
muraglitazar results in decreased expression of LEAP2 mRNA
CTD
PMID:21515302
NCBI chr10:37,580,172...37,581,244
Ensembl chr10:37,577,855...37,581,244
G
Lipe
lipase E, hormone sensitive type
increases expression
EXP
muraglitazar results in increased expression of LIPE mRNA
CTD
PMID:21515302
NCBI chr 1:80,965,612...80,984,313
Ensembl chr 1:80,965,627...80,984,310
G
Liph
lipase H
decreases expression
EXP
muraglitazar results in decreased expression of LIPH mRNA
CTD
PMID:21515302
NCBI chr11:79,032,229...79,081,625
Ensembl chr11:79,033,312...79,081,625
G
Lmod2
leiomodin 2
increases expression
EXP
muraglitazar results in increased expression of LMOD2 mRNA
CTD
PMID:21515302
NCBI chr 4:53,067,428...53,075,124
Ensembl chr 4:53,067,428...53,075,120
G
Lonp2
lon peptidase 2, peroxisomal
increases expression
EXP
muraglitazar results in increased expression of LONP2 mRNA
CTD
PMID:21515302
NCBI chr19:20,407,475...20,498,985
Ensembl chr19:20,407,477...20,499,014
G
Loxl1
lysyl oxidase-like 1
decreases expression
EXP
muraglitazar results in decreased expression of LOXL1 mRNA
CTD
PMID:21515302
NCBI chr 8:58,691,763...58,716,365
Ensembl chr 8:58,692,593...58,716,356
G
Lpcat3
lysophosphatidylcholine acyltransferase 3
increases expression
EXP
muraglitazar results in increased expression of LPCAT3 mRNA
CTD
PMID:21515302
NCBI chr 4:157,468,397...157,509,889
Ensembl chr 4:157,468,290...157,509,880
G
Lrat
lecithin retinol acyltransferase
increases expression
EXP
muraglitazar results in increased expression of LRAT mRNA
CTD
PMID:21515302
NCBI chr 2:168,264,093...168,273,155
Ensembl chr 2:168,266,877...168,273,619
G
Lrp1
LDL receptor related protein 1
increases expression
EXP
muraglitazar results in increased expression of LRP1 mRNA
CTD
PMID:21515302
NCBI chr 7:63,380,325...63,461,029
Ensembl chr 7:63,380,356...63,460,910
G
Ltb
lymphotoxin beta
affects expression
EXP
muraglitazar affects the expression of LTB mRNA
CTD
PMID:21515302
NCBI chr20:3,627,536...3,629,381
Ensembl chr20:3,627,537...3,629,381
G
Ltbp1
latent transforming growth factor beta binding protein 1
increases expression
EXP
muraglitazar results in increased expression of LTBP1 mRNA
CTD
PMID:21515302
NCBI chr 6:20,029,629...20,425,339
Ensembl chr 6:20,029,629...20,425,349
G
Lxn
latexin
decreases expression
EXP
muraglitazar results in decreased expression of LXN mRNA
CTD
PMID:21515302
NCBI chr 2:151,727,556...151,733,426
Ensembl chr 2:151,727,102...151,733,460
G
Ly49i4
Ly49 inhibitory receptor 4
decreases expression
EXP
muraglitazar results in decreased expression of LY49I4 mRNA
CTD
PMID:21515302
NCBI chr 4:164,166,784...164,188,380
Ensembl chr 4:164,122,072...164,341,692
G
Lyc2
lysozyme C type 2
decreases expression
EXP
muraglitazar results in decreased expression of LYC2 mRNA
CTD
PMID:21515302
NCBI chr 7:52,887,104...52,894,447
Ensembl chr 7:52,886,883...52,894,446
G
Lyz2
lysozyme 2
decreases expression
EXP
muraglitazar results in decreased expression of LYZ mRNA
CTD
PMID:21515302
NCBI chr 7:52,906,810...52,912,154
Ensembl chr 7:52,906,811...52,912,106
G
Mall
mal, T-cell differentiation protein-like
increases expression
EXP
muraglitazar results in increased expression of MALL mRNA
CTD
PMID:21515302
NCBI chr 3:114,927,897...114,950,840
Ensembl chr 3:114,927,897...114,950,785
G
Mat1a
methionine adenosyltransferase 1A
increases expression
EXP
muraglitazar results in increased expression of MAT1A mRNA
CTD
PMID:21515302
NCBI chr16:16,983,084...17,001,284
Ensembl chr16:16,983,022...17,001,274
G
Mcoln3
mucolipin TRP cation channel 3
increases expression
EXP
muraglitazar results in increased expression of MCOLN3 mRNA
CTD
PMID:21515302
NCBI chr 2:235,008,716...235,042,885
Ensembl chr 2:234,966,010...235,043,047
G
Mgll
monoglyceride lipase
increases expression
EXP
muraglitazar results in increased expression of MGLL mRNA
CTD
PMID:21515302
NCBI chr 4:121,192,186...121,294,187
Ensembl chr 4:121,192,195...121,294,179
G
Mgp
matrix Gla protein
decreases expression
EXP
muraglitazar results in decreased expression of MGP mRNA
CTD
PMID:21515302
NCBI chr 4:169,766,290...169,769,612
Ensembl chr 4:169,766,279...169,769,667
G
Miox
myo-inositol oxygenase
increases expression
EXP
muraglitazar results in increased expression of MIOX mRNA
CTD
PMID:21515302
NCBI chr 7:120,405,031...120,407,529
Ensembl chr 7:120,405,031...120,407,537
G
Mir16
microRNA 16
increases expression
EXP
muraglitazar results in increased expression of MIR16 mRNA
CTD
PMID:21515302
NCBI chr 2:153,245,349...153,245,443
Ensembl chr 2:153,245,349...153,245,443
G
Mlycd
malonyl-CoA decarboxylase
increases expression
EXP
muraglitazar results in increased expression of MLYCD mRNA
CTD
PMID:21515302
NCBI chr19:47,447,931...47,463,794
Ensembl chr19:47,447,970...47,463,793
G
Mmp10
matrix metallopeptidase 10
decreases expression
EXP
muraglitazar results in decreased expression of MMP10 mRNA
CTD
PMID:21515302
NCBI chr 8:4,689,840...4,697,748
Ensembl chr 8:4,689,840...4,697,748
G
Mmp3
matrix metallopeptidase 3
decreases expression
EXP
muraglitazar results in decreased expression of MMP3 mRNA
CTD
PMID:21515302
NCBI chr 8:4,640,397...4,653,963
Ensembl chr 8:4,640,416...4,653,961
G
Mns1
meiosis-specific nuclear structural 1
decreases expression
EXP
muraglitazar results in decreased expression of MNS1 mRNA
CTD
PMID:21515302
NCBI chr 8:73,148,877...73,169,570
Ensembl chr 8:73,148,877...73,176,925
G
Mocs2
molybdenum cofactor synthesis 2
increases expression
EXP
muraglitazar results in increased expression of MOCS2 mRNA
CTD
PMID:21515302
NCBI chr 2:46,504,588...46,516,327
Ensembl chr 2:46,504,588...46,516,324
G
Morn4
MORN repeat containing 4
decreases expression
EXP
muraglitazar results in decreased expression of MORN4 mRNA
CTD
PMID:21515302
NCBI chr 1:240,888,338...240,898,644
Ensembl chr 1:240,888,344...240,898,716
G
Msx2
msh homeobox 2
increases expression
EXP
muraglitazar results in increased expression of MSX2 mRNA
CTD
PMID:21515302
NCBI chr17:11,097,214...11,102,879
Ensembl chr17:11,097,103...11,102,879
G
Mttp
microsomal triglyceride transfer protein
increases expression
EXP
muraglitazar results in increased expression of MTTP mRNA
CTD
PMID:21515302
NCBI chr 2:226,613,090...226,654,239
Ensembl chr 2:226,613,090...226,654,239
G
Muc13
mucin 13, cell surface associated
increases expression
EXP
muraglitazar results in increased expression of MUC13 mRNA
CTD
PMID:21515302
NCBI chr11:66,957,208...66,980,264
Ensembl chr11:66,960,595...66,984,727
G
Muc2
mucin 2, oligomeric mucus/gel-forming
decreases expression
EXP
muraglitazar results in decreased expression of MUC2 mRNA
CTD
PMID:21515302
NCBI chr 1:196,799,494...196,831,740
Ensembl chr 1:196,799,517...196,831,756
G
N4bp2l1
NEDD4 binding protein 2-like 1
increases expression
EXP
muraglitazar results in increased expression of N4BP2L1 mRNA
CTD
PMID:21515302
NCBI chr12:102,572...128,352
Ensembl chr12:102,573...127,257
G
Napepld
N-acyl phosphatidylethanolamine phospholipase D
increases expression
EXP
muraglitazar results in increased expression of NAPEPLD mRNA
CTD
PMID:21515302
NCBI chr 4:13,360,532...13,398,815
Ensembl chr 4:13,361,006...13,398,748
G
Ndrg1
N-myc downstream regulated 1
increases expression
EXP
muraglitazar results in increased expression of NDRG1 mRNA
CTD
PMID:21515302
NCBI chr 7:98,684,487...98,725,869
Ensembl chr 7:98,684,487...98,725,880
G
Nefm
neurofilament medium chain
decreases expression
EXP
muraglitazar results in decreased expression of NEFM mRNA
CTD
PMID:21515302
NCBI chr15:42,360,449...42,365,753
Ensembl chr15:42,360,454...42,365,755
G
Nell2
neural EGFL like 2
decreases expression
EXP
muraglitazar results in decreased expression of NELL2 mRNA
CTD
PMID:21515302
NCBI chr 7:126,343,089...126,662,903
Ensembl chr 7:126,198,851...126,733,503
G
Nf2
NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor
decreases expression
EXP
muraglitazar results in decreased expression of NF2 mRNA
CTD
PMID:21515302
NCBI chr14:79,627,399...79,710,709
Ensembl chr14:79,627,399...79,710,667
G
Nfkb1
nuclear factor kappa B subunit 1
decreases expression
EXP
muraglitazar results in decreased expression of NFKB1 mRNA
CTD
PMID:21515302
NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:224,016,214...224,110,404
G
Nfkb2
nuclear factor kappa B subunit 2
decreases expression
EXP
muraglitazar results in decreased expression of NFKB2 mRNA
CTD
PMID:21515302
NCBI chr 1:245,164,586...245,173,225
Ensembl chr 1:245,165,950...245,173,213
G
Nid2
nidogen 2
increases expression
EXP
muraglitazar results in increased expression of NID2 mRNA
CTD
PMID:21515302
NCBI chr15:4,458,082...4,513,808
Ensembl chr15:4,458,084...4,513,843
G
Nod2
nucleotide-binding oligomerization domain containing 2
decreases expression
EXP
muraglitazar results in decreased expression of NOD2 mRNA
CTD
PMID:21515302
NCBI chr19:18,382,369...18,422,817
Ensembl chr19:18,382,439...18,417,177
G
Nova1
NOVA alternative splicing regulator 1
increases expression
EXP
muraglitazar results in increased expression of NOVA1 mRNA
CTD
PMID:21515302
NCBI chr 6:63,780,105...63,905,567
Ensembl chr 6:63,783,489...63,906,289
G
Npc1l1
NPC1 like intracellular cholesterol transporter 1
increases expression
EXP
muraglitazar results in increased expression of NPC1L1 mRNA
CTD
PMID:21515302
NCBI chr14:81,071,448...81,091,113
Ensembl chr14:81,071,451...81,091,113
G
Npy
neuropeptide Y
decreases expression
EXP
muraglitazar results in decreased expression of NPY mRNA
CTD
PMID:21515302
NCBI chr 4:78,881,294...78,888,495
Ensembl chr 4:78,881,264...78,888,495
G
Nr1h3
nuclear receptor subfamily 1, group H, member 3
multiple interactions
ISO
[Oleic Acid co-treated with muraglitazar] results in increased expression of NR1H3 mRNA
CTD
PMID:24534255
NCBI chr 3:77,158,808...77,168,907
Ensembl chr 3:77,158,808...77,168,722
G
Nr1h4
nuclear receptor subfamily 1, group H, member 4
multiple interactions
ISO
[Oleic Acid co-treated with muraglitazar] results in increased expression of NR1H4 mRNA
CTD
PMID:24534255
NCBI chr 7:23,846,122...23,942,085
Ensembl chr 7:23,846,122...23,942,047
G
Nr1i3
nuclear receptor subfamily 1, group I, member 3
increases expression multiple interactions
EXP ISO
muraglitazar results in increased expression of NR1I3 mRNA [Oleic Acid co-treated with muraglitazar] results in increased expression of NR1I3 mRNA
CTD
PMID:21515302 PMID:24534255
NCBI chr13:83,632,940...83,638,193
Ensembl chr13:83,632,899...83,637,906
G
Nr4a1
nuclear receptor subfamily 4, group A, member 1
decreases expression
EXP
muraglitazar results in decreased expression of NR4A1 mRNA
CTD
PMID:21515302
NCBI chr 7:132,368,399...132,389,300
Ensembl chr 7:132,374,840...132,389,297
G
Nrp2
neuropilin 2
decreases expression
EXP
muraglitazar results in decreased expression of NRP2 mRNA
CTD
PMID:21515302
NCBI chr 9:64,122,815...64,238,007
Ensembl chr 9:64,123,132...64,237,958
G
Ntrk1
neurotrophic receptor tyrosine kinase 1
increases expression
EXP
muraglitazar results in increased expression of NTRK1 mRNA
CTD
PMID:21515302
NCBI chr 2:173,236,961...173,253,806
Ensembl chr 2:173,236,963...173,253,770
G
Oat
ornithine aminotransferase
increases expression
EXP
muraglitazar results in increased expression of OAT mRNA
CTD
PMID:21515302
NCBI chr 1:187,347,862...187,367,644
Ensembl chr 1:187,347,865...187,367,682
G
Obp1f
odorant binding protein I f
increases expression
EXP
muraglitazar results in increased expression of OBP1F mRNA
CTD
PMID:21515302
NCBI chr X:41,955,618...41,960,681
Ensembl chr X:41,955,618...41,960,681
G
Oit3
oncoprotein induced transcript 3
decreases expression
EXP
muraglitazar results in decreased expression of OIT3 mRNA
CTD
PMID:21515302
NCBI chr20:27,390,113...27,410,692
Ensembl chr20:27,390,113...27,410,692
G
Olr981-ps
olfactory receptor pseudogene 981
decreases expression
EXP
muraglitazar results in decreased expression of OLR981-PS mRNA
CTD
PMID:21515302
NCBI chr 7:4,448,410...4,449,130
G
Oplah
5-oxoprolinase (ATP-hydrolysing)
increases expression
EXP
muraglitazar results in increased expression of OPLAH mRNA
CTD
PMID:21515302
NCBI chr 7:108,011,472...108,051,751
Ensembl chr 7:108,011,475...108,035,297
G
Osbpl5
oxysterol binding protein-like 5
decreases expression
EXP
muraglitazar results in decreased expression of OSBPL5 mRNA
CTD
PMID:21515302
NCBI chr 1:198,862,071...198,916,469
Ensembl chr 1:198,862,055...198,916,469
G
Ostn
osteocrin
decreases expression
EXP
muraglitazar results in decreased expression of OSTN mRNA
CTD
PMID:21515302
NCBI chr11:73,442,167...73,478,498
Ensembl chr11:73,442,487...73,468,603
G
Parm1
prostate androgen-regulated mucin-like protein 1
increases expression
EXP
muraglitazar results in increased expression of PARM1 mRNA
CTD
PMID:21515302
NCBI chr14:16,468,309...16,577,339
Ensembl chr14:16,468,459...16,577,314
G
Patj
PATJ, crumbs cell polarity complex component
increases expression
EXP
muraglitazar results in increased expression of PATJ mRNA
CTD
PMID:21515302
NCBI chr 5:113,061,985...113,364,807
Ensembl chr 5:113,062,118...113,364,807
G
Pbld1
phenazine biosynthesis-like protein domain containing 1
decreases expression
EXP
muraglitazar results in decreased expression of PBLD mRNA
CTD
PMID:21515302
NCBI chr20:25,551,274...25,566,543
Ensembl chr20:25,551,275...25,565,614
G
Pc
pyruvate carboxylase
increases expression
EXP
muraglitazar results in increased expression of PC mRNA
CTD
PMID:21515302
NCBI chr 1:201,799,374...201,898,412
Ensembl chr 1:201,804,267...201,898,380
G
Pck1
phosphoenolpyruvate carboxykinase 1
increases expression
EXP
muraglitazar results in increased expression of PCK1 mRNA
CTD
PMID:21515302
NCBI chr 3:161,930,256...161,936,205
Ensembl chr 3:161,930,256...161,936,191
G
Pde1a
phosphodiesterase 1A
decreases expression
EXP
muraglitazar results in decreased expression of PDE1A mRNA
CTD
PMID:21515302
NCBI chr 3:64,745,140...65,025,178
Ensembl chr 3:64,747,269...65,024,874
G
Pdgfrb
platelet derived growth factor receptor beta
increases expression
EXP
muraglitazar results in increased expression of PDGFRB mRNA
CTD
PMID:21515302
NCBI chr18:54,499,962...54,538,840
Ensembl chr18:54,499,964...54,538,843
G
Pdk4
pyruvate dehydrogenase kinase 4
increases expression
EXP
muraglitazar results in increased expression of PDK4 mRNA
CTD
PMID:21515302
NCBI chr 4:33,591,796...33,601,798
Ensembl chr 4:33,589,799...33,601,850
G
Pdxk
pyridoxal kinase
increases expression
EXP
muraglitazar results in increased expression of PDXK mRNA
CTD
PMID:21515302
NCBI chr20:10,210,276...10,232,314
Ensembl chr20:10,210,289...10,232,110
G
Pdzk1
PDZ domain containing 1
increases expression
EXP
muraglitazar results in increased expression of PDZK1 mRNA
CTD
PMID:21515302
NCBI chr 2:184,376,161...184,407,514
Ensembl chr 2:184,376,161...184,407,514
G
Pea15
proliferation and apoptosis adaptor protein 15
decreases expression
EXP
muraglitazar results in decreased expression of PEA15 mRNA
CTD
PMID:21515302
NCBI chr13:84,657,815...84,667,437
Ensembl chr13:84,654,870...84,667,499
G
Pex11a
peroxisomal biogenesis factor 11 alpha
increases expression
EXP
muraglitazar results in increased expression of PEX11A mRNA
CTD
PMID:21515302
NCBI chr 1:133,680,091...133,687,172
Ensembl chr 1:133,680,091...133,687,172
G
Pex16
peroxisomal biogenesis factor 16
increases expression
EXP
muraglitazar results in increased expression of PEX16 mRNA
CTD
PMID:21515302
NCBI chr 3:78,347,212...78,352,603
Ensembl chr 3:78,343,164...78,353,207
G
Pex19
peroxisomal biogenesis factor 19
increases expression
EXP
muraglitazar results in increased expression of PEX19 mRNA
CTD
PMID:21515302
NCBI chr13:84,592,277...84,608,793
Ensembl chr13:84,592,312...84,608,608
G
Pfkl
phosphofructokinase, liver type
increases expression
EXP
muraglitazar results in increased expression of PFKL mRNA
CTD
PMID:21515302
NCBI chr20:10,664,285...10,686,324
Ensembl chr20:10,664,272...10,686,315
G
Pgk1
phosphoglycerate kinase 1
increases expression
EXP
muraglitazar results in increased expression of PGK1 mRNA
CTD
PMID:21515302
NCBI chr X:71,271,454...71,287,429
Ensembl chr X:71,271,440...71,287,418
G
Pgrmc2
progesterone receptor membrane component 2
increases expression
EXP
muraglitazar results in increased expression of PGRMC2 mRNA
CTD
PMID:21515302
NCBI chr 2:124,068,257...124,084,155
Ensembl chr 2:124,068,260...124,084,155
G
Phlda1
pleckstrin homology-like domain, family A, member 1
decreases expression
EXP
muraglitazar results in decreased expression of PHLDA1 mRNA
CTD
PMID:21515302
NCBI chr 7:46,967,433...46,969,637
Ensembl chr 7:46,967,409...46,969,861
G
Phldb1
pleckstrin homology-like domain, family B, member 1
decreases expression
EXP
muraglitazar results in decreased expression of PHLDB1 mRNA
CTD
PMID:21515302
NCBI chr 8:45,003,543...45,051,541
Ensembl chr 8:45,003,538...45,051,522
G
Phyh
phytanoyl-CoA 2-hydroxylase
increases expression
EXP
muraglitazar results in increased expression of PHYH mRNA
CTD
PMID:21515302
NCBI chr17:73,329,461...73,346,359
Ensembl chr17:73,329,082...73,346,409
G
Pla1a
phospholipase A1 member A
decreases expression
EXP
muraglitazar results in decreased expression of PLA1A mRNA
CTD
PMID:21515302
NCBI chr11:62,320,112...62,357,779
Ensembl chr11:62,320,493...62,357,779
G
Plaat3
phospholipase A and acyltransferase 3
decreases expression
EXP
muraglitazar results in decreased expression of PLAAT3 mRNA
CTD
PMID:21515302
NCBI chr 1:204,782,608...204,816,397
Ensembl chr 1:204,782,729...204,817,667
G
Plbd1
phospholipase B domain containing 1
increases expression
EXP
muraglitazar results in increased expression of PLBD1 mRNA
CTD
PMID:21515302
NCBI chr 4:169,472,983...169,529,277
Ensembl chr 4:169,472,983...169,529,277
G
Plekho1
pleckstrin homology domain containing O1
decreases expression
EXP
muraglitazar results in decreased expression of PLEKHO1 mRNA
CTD
PMID:21515302
NCBI chr 2:183,544,487...183,552,928
Ensembl chr 2:183,544,499...183,552,785
G
Plin2
perilipin 2
multiple interactions
ISO
muraglitazar promotes the reaction [Oleic Acid results in increased expression of PLIN2 mRNA]
CTD
PMID:24534255
NCBI chr 5:101,156,648...101,211,738
Ensembl chr 5:101,154,411...101,242,319
G
Plin4
perilipin 4
multiple interactions
ISO
muraglitazar promotes the reaction [Oleic Acid results in increased expression of PLIN4 mRNA]
CTD
PMID:24534255
NCBI chr 9:929,168...938,062
Ensembl chr 9:929,176...938,056
G
Plin5
perilipin 5
increases expression
EXP
muraglitazar results in increased expression of PLIN5 mRNA
CTD
PMID:21515302
NCBI chr 9:939,745...946,188
Ensembl chr 9:939,747...946,120
G
Plscr2
phospholipid scramblase 2
decreases expression
EXP
muraglitazar results in decreased expression of PLSCR2 mRNA
CTD
PMID:21515302
NCBI chr 8:92,809,422...92,845,947
Ensembl chr 8:92,808,398...92,845,932
G
Por
cytochrome p450 oxidoreductase
increases expression
EXP
muraglitazar results in increased expression of POR mRNA
CTD
PMID:21515302
NCBI chr12:20,951,058...20,999,198
Ensembl chr12:20,951,058...20,999,245
G
Ppara
peroxisome proliferator activated receptor alpha
increases expression multiple interactions
EXP ISO
muraglitazar results in increased expression of PPARA mRNA muraglitazar binds to and results in increased activity of PPARA protein
CTD
PMID:17426106 PMID:17675651 PMID:21515302
NCBI chr 7:116,832,405...116,900,878
Ensembl chr 7:116,832,756...116,895,346
G
Pparg
peroxisome proliferator-activated receptor gamma
multiple interactions decreases expression
ISO EXP
muraglitazar binds to and results in increased activity of PPARG protein muraglitazar results in decreased expression of PPARG mRNA
CTD
PMID:17426106 PMID:17675651 PMID:21515302
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
G
Ppcs
phosphopantothenoylcysteine synthetase
increases expression
EXP
muraglitazar results in increased expression of PPCS mRNA
CTD
PMID:21515302
NCBI chr 5:133,023,077...133,026,899
Ensembl chr 5:133,023,121...133,026,933
G
Prm2
protamine 2
decreases expression
EXP
muraglitazar results in decreased expression of PRM2 mRNA
CTD
PMID:21515302
NCBI chr10:4,876,285...4,877,026
Ensembl chr10:4,873,372...4,877,026
G
Prom1
prominin 1
decreases expression
EXP
muraglitazar results in decreased expression of PROM1 mRNA
CTD
PMID:21515302
NCBI chr14:66,989,545...67,094,534
Ensembl chr14:66,990,160...67,094,527
G
Prss8
serine protease 8
decreases expression
EXP
muraglitazar results in decreased expression of PRSS8 mRNA
CTD
PMID:21515302
NCBI chr 1:182,536,229...182,540,745
Ensembl chr 1:182,536,229...182,540,815
G
Psat1
phosphoserine aminotransferase 1
increases expression
EXP
muraglitazar results in increased expression of PSAT1 mRNA
CTD
PMID:21515302
NCBI chr 1:213,196,709...213,218,564
Ensembl chr 1:213,196,709...213,218,682
G
Pxdc1
PX domain containing 1
decreases expression
EXP
muraglitazar results in decreased expression of PXDC1 mRNA
CTD
PMID:21515302
NCBI chr17:30,275,998...30,304,971
Ensembl chr17:30,276,377...30,304,973
G
Pygl
glycogen phosphorylase L
increases expression
EXP
muraglitazar results in increased expression of PYGL mRNA
CTD
PMID:21515302
NCBI chr 6:88,697,598...88,740,260
Ensembl chr 6:88,697,593...88,740,310
G
Qrfpr
pyroglutamylated RFamide peptide receptor
decreases expression
EXP
muraglitazar results in decreased expression of QRFPR mRNA
CTD
PMID:21515302
NCBI chr 2:119,053,083...119,096,864
Ensembl chr 2:119,053,511...119,096,792
G
Rab19
RAB19, member RAS oncogene family
decreases expression
EXP
muraglitazar results in decreased expression of RAB19 mRNA
CTD
PMID:21515302
NCBI chr 4:68,157,159...68,166,889
Ensembl chr 4:68,156,881...68,166,886
G
Rab9a
RAB9A, member RAS oncogene family
increases expression
EXP
muraglitazar results in increased expression of RAB9 mRNA
CTD
PMID:21515302
NCBI chr X:27,955,552...28,009,870
Ensembl chr X:27,952,204...28,001,622
G
Rai14
retinoic acid induced 14
decreases expression
EXP
muraglitazar results in decreased expression of RAI14 mRNA
CTD
PMID:21515302
NCBI chr 2:59,546,284...59,682,687
Ensembl chr 2:59,546,284...59,681,971
G
Ramp1
receptor activity modifying protein 1
increases expression
EXP
muraglitazar results in increased expression of RAMP1 mRNA
CTD
PMID:21515302
NCBI chr 9:91,765,481...91,816,152
Ensembl chr 9:91,781,285...91,816,151
G
Rasa3
RAS p21 protein activator 3
decreases expression
EXP
muraglitazar results in decreased expression of RASA3 mRNA
CTD
PMID:21515302
NCBI chr16:75,855,360...75,969,349
Ensembl chr16:75,855,265...75,970,804
G
Rassf9
Ras association domain family member 9
decreases expression
EXP
muraglitazar results in decreased expression of RASSF9 mRNA
CTD
PMID:21515302
NCBI chr 7:37,599,720...37,631,553
Ensembl chr 7:37,599,720...37,635,245
G
Rcor2
REST corepressor 2
increases expression
EXP
muraglitazar results in increased expression of RCOR2 mRNA
CTD
PMID:21515302
NCBI chr 1:204,453,403...204,461,403
Ensembl chr 1:204,454,360...204,460,838
G
Rec8
REC8 meiotic recombination protein
increases expression
EXP
muraglitazar results in increased expression of REC8 mRNA
CTD
PMID:21515302
NCBI chr15:29,109,862...29,117,327
Ensembl chr15:29,109,863...29,117,326
G
Reg4
regenerating family member 4
decreases expression
EXP
muraglitazar results in decreased expression of REG4 mRNA
CTD
PMID:21515302
NCBI chr 2:185,818,946...185,833,252
Ensembl chr 2:185,821,210...185,833,353
G
Retsat
retinol saturase
increases expression
EXP
muraglitazar results in increased expression of RETSAT mRNA
CTD
PMID:21515302
NCBI chr 4:104,653,306...104,662,069
Ensembl chr 4:104,653,155...104,668,310
G
Rgs2
regulator of G-protein signaling 2
decreases expression
EXP
muraglitazar results in decreased expression of RGS2 mRNA
CTD
PMID:21515302
NCBI chr13:55,799,749...55,802,354
Ensembl chr13:55,798,829...55,802,385
G
Rgs4
regulator of G-protein signaling 4
increases expression
EXP
muraglitazar results in increased expression of RGS4 mRNA
CTD
PMID:21515302
NCBI chr13:81,936,775...81,943,103
Ensembl chr13:81,936,775...81,943,068
G
Rnase1
ribonuclease A family member 1, pancreatic
decreases expression
EXP
muraglitazar results in decreased expression of RNASE1 mRNA
CTD
PMID:21515302
NCBI chr15:24,361,924...24,363,633
Ensembl chr15:24,361,927...24,363,624
G
Rnase3
ribonuclease A family member 3
decreases expression
EXP
muraglitazar results in decreased expression of RNASE3 mRNA
CTD
PMID:21515302
NCBI chr15:24,511,894...24,512,764
Ensembl chr15:24,511,891...24,512,790
G
Ropn1l
rhophilin associated tail protein 1-like
decreases expression
EXP
muraglitazar results in decreased expression of ROPN1L mRNA
CTD
PMID:21515302
NCBI chr 2:82,442,645...82,453,332
Ensembl chr 2:82,441,891...82,453,485
G
RT1-M3-1
RT1 class Ib, locus M3, gene 1
decreases expression
EXP
muraglitazar results in decreased expression of RT1-M3-1 mRNA
CTD
PMID:21515302
NCBI chr20:1,323,976...1,328,126
Ensembl chr20:1,287,521...1,328,117
G
Runx1
RUNX family transcription factor 1
decreases expression
EXP
muraglitazar results in decreased expression of RUNX1 mRNA
CTD
PMID:21515302
NCBI chr11:31,839,880...32,074,427
Ensembl chr11:31,843,764...32,074,542
G
Rxfp2
relaxin family peptide receptor 2
decreases expression
EXP
muraglitazar results in decreased expression of RXFP2 mRNA
CTD
PMID:21515302
NCBI chr12:4,924,747...4,986,672
Ensembl chr12:4,925,722...4,986,596
G
Rxrg
retinoid X receptor gamma
increases expression
EXP
muraglitazar results in increased expression of RXRG mRNA
CTD
PMID:21515302
NCBI chr13:79,743,430...79,785,173
Ensembl chr13:79,743,563...79,785,167
G
S100a1
S100 calcium binding protein A1
decreases expression
EXP
muraglitazar results in decreased expression of S100A1 mRNA
CTD
PMID:21515302
NCBI chr 2:175,993,922...175,998,765
Ensembl chr 2:175,993,922...175,999,544
G
S100a6
S100 calcium binding protein A6
decreases expression
EXP
muraglitazar results in decreased expression of S100A6 mRNA
CTD
PMID:21515302
NCBI chr 2:176,100,619...176,102,181
Ensembl chr 2:176,100,899...176,102,180
G
Scd
stearoyl-CoA desaturase
multiple interactions increases expression
ISO EXP
[Oleic Acid co-treated with muraglitazar] results in increased expression of SCD1 mRNA muraglitazar results in increased expression of SCD1 mRNA
CTD
PMID:21515302 PMID:24534255
NCBI chr 1:243,269,745...243,282,878
Ensembl chr 1:243,269,747...243,282,562
G
Scn3a
sodium voltage-gated channel alpha subunit 3
decreases expression
EXP
muraglitazar results in decreased expression of SCN3A mRNA
CTD
PMID:21515302
NCBI chr 3:50,146,411...50,258,119
Ensembl chr 3:50,148,139...50,258,119
G
Scrg1
stimulator of chondrogenesis 1
decreases expression
EXP
muraglitazar results in decreased expression of SCRG1 mRNA
CTD
PMID:21515302
NCBI chr16:32,760,028...32,788,299
Ensembl chr16:32,760,028...32,788,299
G
Selenop
selenoprotein P
decreases expression
EXP
muraglitazar results in decreased expression of SELENOP mRNA
CTD
PMID:21515302
NCBI chr 2:52,498,123...52,508,409
Ensembl chr 2:52,498,339...52,508,852
G
Sema4a
semaphorin 4A
decreases expression
EXP
muraglitazar results in decreased expression of SEMA4A mRNA
CTD
PMID:21515302
NCBI chr 2:173,896,432...173,917,903
Ensembl chr 2:173,896,439...173,914,442
G
Serinc2
serine incorporator 2
decreases expression
EXP
muraglitazar results in decreased expression of SERINC2 mRNA
CTD
PMID:21515302
NCBI chr 5:142,592,308...142,614,628
Ensembl chr 5:142,592,309...142,618,364
G
Serpinb5
serpin family B member 5
increases expression
EXP
muraglitazar results in increased expression of SERPINB5 mRNA
CTD
PMID:21515302
NCBI chr13:22,985,557...23,005,756
Ensembl chr13:22,985,557...23,005,756
G
Serpine1
serpin family E member 1
increases expression
EXP
muraglitazar results in increased expression of SERPINE1 mRNA
CTD
PMID:21515302
NCBI chr12:19,601,272...19,611,657
Ensembl chr12:19,601,272...19,611,657
G
Serpine2
serpin family E member 2
increases expression
EXP
muraglitazar results in increased expression of SERPINE2 mRNA
CTD
PMID:21515302
NCBI chr 9:81,124,746...81,188,866
Ensembl chr 9:81,124,804...81,188,826
G
Sfxn3
sideroflexin 3
decreases expression
EXP
muraglitazar results in decreased expression of SFXN3 mRNA
CTD
PMID:21515302
NCBI chr 1:243,907,958...243,917,065
Ensembl chr 1:243,907,751...243,917,073
G
Sgcg
sarcoglycan, gamma
decreases expression
EXP
muraglitazar results in decreased expression of SGCG mRNA
CTD
PMID:21515302
NCBI chr15:35,388,836...35,435,072
Ensembl chr15:35,386,534...35,435,148
G
Sirpa
signal-regulatory protein alpha
decreases expression
EXP
muraglitazar results in decreased expression of SIRPA mRNA
CTD
PMID:21515302
NCBI chr 3:116,819,730...116,858,099
Ensembl chr 3:116,819,726...116,858,098
G
Slain1
SLAIN motif family, member 1
decreases expression
EXP
muraglitazar results in decreased expression of SLAIN1 mRNA
CTD
PMID:21515302
NCBI chr15:80,482,818...80,542,461
Ensembl chr15:80,482,367...80,542,350
G
Slc10a2
solute carrier family 10 member 2
decreases expression
EXP
muraglitazar results in decreased expression of SLC10A2 mRNA
CTD
PMID:21515302
NCBI chr16:84,386,528...84,409,475
Ensembl chr16:84,374,862...84,409,475
G
Slc12a1
solute carrier family 12 member 1
decreases expression
EXP
muraglitazar results in decreased expression of SLC12A1 mRNA
CTD
PMID:21515302
NCBI chr 3:112,406,140...112,482,913
Ensembl chr 3:112,406,140...112,482,899
G
Slc17a8
solute carrier family 17 member 8
decreases expression
EXP
muraglitazar results in decreased expression of SLC17A8 mRNA
CTD
PMID:21515302
NCBI chr 7:23,994,212...24,049,498
Ensembl chr 7:23,994,217...24,048,079
G
Slc22a22
solute carrier family 22 member 22
decreases expression
EXP
muraglitazar results in decreased expression of SLC22A22 mRNA
CTD
PMID:21515302
NCBI chr 7:88,720,425...88,750,111
Ensembl chr 7:88,720,427...88,750,111
G
Slc22a5
solute carrier family 22 member 5
increases expression
EXP
muraglitazar results in increased expression of SLC22A5 mRNA
CTD
PMID:21515302
NCBI chr10:38,008,303...38,035,474
Ensembl chr10:38,008,311...38,035,309
G
Slc24a2
solute carrier family 24 member 2
decreases expression
EXP
muraglitazar results in decreased expression of SLC24A2 mRNA
CTD
PMID:21515302
NCBI chr 5:101,497,916...101,741,840
Ensembl chr 5:101,502,278...101,739,337
G
Slc25a20
solute carrier family 25 member 20
increases expression
EXP
muraglitazar results in increased expression of SLC25A20 mRNA
CTD
PMID:21515302
NCBI chr 8:109,365,056...109,386,512
Ensembl chr 8:109,365,002...109,386,512
G
Slc25a34
solute carrier family 25, member 34
increases expression
EXP
muraglitazar results in increased expression of SLC25A34 mRNA
CTD
PMID:21515302
NCBI chr 5:153,932,081...153,936,854
G
Slc25a42
solute carrier family 25, member 42
increases expression
EXP
muraglitazar results in increased expression of SLC25A42 mRNA
CTD
PMID:21515302
NCBI chr16:19,213,914...19,251,990
Ensembl chr16:19,213,950...19,237,025
G
Slc27a2
solute carrier family 27 member 2
increases expression
EXP
muraglitazar results in increased expression of SLC27A2 mRNA
CTD
PMID:21515302
NCBI chr 3:113,804,728...113,842,208
Ensembl chr 3:113,804,728...113,842,208
G
Slc2a2
solute carrier family 2 member 2
decreases expression
EXP
muraglitazar results in decreased expression of SLC2A2 mRNA
CTD
PMID:21515302
NCBI chr 2:111,609,798...111,639,930
Ensembl chr 2:111,611,774...111,639,933
G
Slc30a2
solute carrier family 30 member 2
increases expression
EXP
muraglitazar results in increased expression of SLC30A2 mRNA
CTD
PMID:21515302
NCBI chr 5:146,559,733...146,571,957
Ensembl chr 5:146,559,733...146,571,956
G
Slc34a2
solute carrier family 34 member 2
increases expression
EXP
muraglitazar results in increased expression of SLC34A2 mRNA
CTD
PMID:21515302
NCBI chr14:57,910,931...57,930,236
Ensembl chr14:57,910,480...57,930,436
G
Slc34a3
solute carrier family 34 member 3
decreases expression
EXP
muraglitazar results in decreased expression of SLC34A3 mRNA
CTD
PMID:21515302
NCBI chr 3:8,044,294...8,050,034
Ensembl chr 3:8,044,296...8,049,970
G
Slc46a3
solute carrier family 46, member 3
decreases expression
EXP
muraglitazar results in decreased expression of SLC46A3 mRNA
CTD
PMID:21515302
NCBI chr12:7,140,610...7,157,093
Ensembl chr12:7,140,668...7,157,092
G
Slc4a4
solute carrier family 4 member 4
increases expression
EXP
muraglitazar results in increased expression of SLC4A4 mRNA
CTD
PMID:21515302
NCBI chr14:18,841,289...19,293,297
Ensembl chr14:18,845,159...19,272,883
G
Slc6a13
solute carrier family 6 member 13
increases expression
EXP
muraglitazar results in increased expression of SLC6A13 mRNA
CTD
PMID:21515302
NCBI chr 4:154,539,246...154,577,784
Ensembl chr 4:154,540,468...154,576,152
G
Slc6a18
solute carrier family 6 member 18
decreases expression
EXP
muraglitazar results in decreased expression of SLC6A18 mRNA
CTD
PMID:21515302
NCBI chr 1:29,607,288...29,621,925
Ensembl chr 1:29,608,077...29,621,925
G
Slco1a4
solute carrier organic anion transporter family, member 1a4
increases expression
EXP
muraglitazar results in increased expression of SLCO1A4 mRNA
CTD
PMID:21515302
NCBI chr 4:174,710,004...174,764,810
Ensembl chr 4:174,710,004...175,254,573
G
Slco3a1
solute carrier organic anion transporter family, member 3a1
decreases expression
EXP
muraglitazar results in decreased expression of SLCO3A1 mRNA
CTD
PMID:21515302
NCBI chr 1:128,106,232...128,388,043
Ensembl chr 1:128,106,228...128,387,925
G
Slit2
slit guidance ligand 2
decreases expression
EXP
muraglitazar results in decreased expression of SLIT2 mRNA
CTD
PMID:21515302
NCBI chr14:62,616,337...62,955,934
Ensembl chr14:62,617,067...62,955,948
G
Smad3
SMAD family member 3
decreases expression
EXP
muraglitazar results in decreased expression of SMAD3 mRNA
CTD
PMID:21515302
NCBI chr 8:64,126,829...64,236,960
Ensembl chr 8:64,110,039...64,236,960
G
Smim3
small integral membrane protein 3
decreases expression
EXP
muraglitazar results in decreased expression of SMIM3 mRNA
CTD
PMID:21515302
NCBI chr18:53,930,019...53,982,339
Ensembl chr18:53,930,020...53,957,416
G
Smoc1
SPARC related modular calcium binding 1
increases expression
EXP
muraglitazar results in increased expression of SMOC1 mRNA
CTD
PMID:21515302
NCBI chr 6:100,701,330...100,897,441
Ensembl chr 6:100,701,346...100,862,699
G
Smpx
small muscle protein, X-linked
decreases expression
EXP
muraglitazar results in decreased expression of SMPX mRNA
CTD
PMID:21515302
NCBI chr X:37,233,209...37,292,266
Ensembl chr X:37,234,294...37,276,708
G
Snx10
sorting nexin 10
increases expression
EXP
muraglitazar results in increased expression of SNX10 mRNA
CTD
PMID:21515302
NCBI chr 4:80,612,648...80,677,005
Ensembl chr 4:80,612,669...80,676,996
G
Soat2
sterol O-acyltransferase 2
increases expression
EXP
muraglitazar results in increased expression of SOAT2 mRNA
CTD
PMID:21515302
NCBI chr 7:133,281,818...133,294,915
Ensembl chr 7:133,281,818...133,294,915
G
Sorbs1
sorbin and SH3 domain containing 1
increases expression
EXP
muraglitazar results in increased expression of SORBS1 mRNA
CTD
PMID:21515302
NCBI chr 1:239,107,882...239,330,276
Ensembl chr 1:239,108,777...239,330,169
G
Speg
striated muscle enriched protein kinase
increases expression
EXP
muraglitazar results in increased expression of SPEG mRNA
CTD
PMID:21515302
NCBI chr 9:76,865,714...76,923,170
Ensembl chr 9:76,865,754...76,923,144
G
Spp1
secreted phosphoprotein 1
decreases expression
EXP
muraglitazar results in decreased expression of SPP1 mRNA
CTD
PMID:21515302
NCBI chr14:5,308,885...5,315,120
Ensembl chr14:5,308,885...5,315,162
G
Spry2
sprouty RTK signaling antagonist 2
decreases expression
EXP
muraglitazar results in decreased expression of SPRY2 mRNA
CTD
PMID:21515302
NCBI chr15:82,692,291...82,697,408
Ensembl chr15:82,692,143...82,698,009
G
Spsb2
splA/ryanodine receptor domain and SOCS box containing 2
decreases expression
EXP
muraglitazar results in decreased expression of SPSB2 mRNA
CTD
PMID:21515302
NCBI chr 4:157,613,404...157,615,293
Ensembl chr 4:157,613,401...157,615,284
G
Srebf1
sterol regulatory element binding transcription factor 1
increases expression
EXP
muraglitazar results in increased expression of SREBF1 mRNA
CTD
PMID:21515302
NCBI chr10:45,007,637...45,029,650
Ensembl chr10:45,007,637...45,029,650
G
Sstr3
somatostatin receptor 3
decreases expression
EXP
muraglitazar results in decreased expression of SSTR3 mRNA
CTD
PMID:21515302
NCBI chr 7:110,092,563...110,109,043
Ensembl chr 7:110,092,575...110,099,769
G
Sstr5
somatostatin receptor 5
increases expression
EXP
muraglitazar results in increased expression of SSTR5 mRNA
CTD
PMID:21515302
NCBI chr10:14,506,868...14,512,946
Ensembl chr10:14,506,868...14,512,946
G
Stc2
stanniocalcin 2
increases expression
EXP
muraglitazar results in increased expression of STC2 mRNA
CTD
PMID:21515302
NCBI chr10:16,251,046...16,260,815
Ensembl chr10:16,250,853...16,262,973
G
Steap4
STEAP4 metalloreductase
decreases expression
EXP
muraglitazar results in decreased expression of STEAP4 mRNA
CTD
PMID:21515302
NCBI chr 4:26,077,182...26,099,859
Ensembl chr 4:26,054,671...26,099,859
G
Stmn4
stathmin 4
decreases expression
EXP
muraglitazar results in decreased expression of STMN4 mRNA
CTD
PMID:21515302
NCBI chr15:40,541,305...40,559,253
Ensembl chr15:40,541,357...40,559,253
G
Sulf1
sulfatase 1
decreases expression
EXP
muraglitazar results in decreased expression of SULF1 mRNA
CTD
PMID:21515302
NCBI chr 5:6,362,894...6,526,174
Ensembl chr 5:6,362,911...6,525,584
G
Sytl5
synaptotagmin-like 5
decreases expression
EXP
muraglitazar results in decreased expression of SYTL5 mRNA
CTD
PMID:21515302
NCBI chr X:12,775,529...13,030,134
Ensembl chr X:12,788,698...13,030,175
G
Tagln
transgelin
decreases expression
EXP
muraglitazar results in decreased expression of TAGLN mRNA
CTD
PMID:21515302
NCBI chr 8:46,224,939...46,230,413
Ensembl chr 8:46,222,472...46,230,668
G
Tat
tyrosine aminotransferase
increases expression
EXP
muraglitazar results in increased expression of TAT mRNA
CTD
PMID:21515302
NCBI chr19:37,947,153...37,957,717
Ensembl chr19:37,947,112...37,958,031
G
Tbc1d21
TBC1 domain family, member 21
decreases expression
EXP
muraglitazar results in decreased expression of TBC1D21 mRNA
CTD
PMID:21515302
NCBI chr 8:58,761,562...58,773,711
Ensembl chr 8:58,761,563...58,773,711
G
Tbx3
T-box transcription factor 3
increases expression
EXP
muraglitazar results in increased expression of TBX3 mRNA
CTD
PMID:21515302
NCBI chr12:36,879,924...36,894,849
Ensembl chr12:36,881,445...36,893,708
G
Tenm2
teneurin transmembrane protein 2
increases expression
EXP
muraglitazar results in increased expression of TENM2 mRNA
CTD
PMID:21515302
NCBI chr10:20,480,662...21,706,415
Ensembl chr10:20,481,854...21,705,597
G
Tgfb2
transforming growth factor, beta 2
increases expression
EXP
muraglitazar results in increased expression of TGFB2 mRNA
CTD
PMID:21515302
NCBI chr13:98,160,075...98,261,771
Ensembl chr13:98,160,087...98,261,405
G
Tgfb3
transforming growth factor, beta 3
decreases expression
EXP
muraglitazar results in decreased expression of TGFB3 mRNA
CTD
PMID:21515302
NCBI chr 6:105,704,058...105,726,661
Ensembl chr 6:105,704,236...105,726,564
G
Tgm1
transglutaminase 1
decreases expression
EXP
muraglitazar results in decreased expression of TGM1 mRNA
CTD
PMID:21515302
NCBI chr15:29,191,039...29,206,000
Ensembl chr15:29,191,041...29,204,523
G
Tgm2
transglutaminase 2
increases expression
EXP
muraglitazar results in increased expression of TGM2 mRNA
CTD
PMID:21515302
NCBI chr 3:146,772,684...146,801,924
Ensembl chr 3:146,772,687...146,801,981
G
Timm10b
translocase of inner mitochondrial membrane 10B
increases expression
EXP
muraglitazar results in increased expression of TIMM10B mRNA
CTD
PMID:21515302
NCBI chr 1:159,980,525...159,983,371
Ensembl chr 1:159,980,484...159,981,642
G
Timp1
TIMP metallopeptidase inhibitor 1
decreases expression
EXP
muraglitazar results in decreased expression of TIMP1 mRNA
CTD
PMID:21515302
NCBI chr X:1,212,969...1,217,714
Ensembl chr X:1,212,972...1,217,664
G
Tinagl1
tubulointerstitial nephritis antigen-like 1
increases expression
EXP
muraglitazar results in increased expression of TINAGL1 mRNA
CTD
PMID:21515302
NCBI chr 5:142,513,710...142,523,730
Ensembl chr 5:142,513,714...142,523,720
G
Tlr6
toll-like receptor 6
decreases expression
EXP
muraglitazar results in decreased expression of TLR6 mRNA
CTD
PMID:21515302
NCBI chr14:43,362,164...43,374,500
Ensembl chr14:43,362,164...43,375,685
G
Tm4sf4
transmembrane 4 L six family member 4
increases expression
EXP
muraglitazar results in increased expression of TM4SF4 mRNA
CTD
PMID:21515302
NCBI chr 2:141,570,321...141,621,263
Ensembl chr 2:141,481,902...141,621,200
G
Tmem14c
transmembrane protein 14C
increases expression
EXP
muraglitazar results in increased expression of TMEM14C mRNA
CTD
PMID:21515302
NCBI chr17:23,733,769...23,739,906
Ensembl chr17:23,733,894...23,753,320
G
Tmsb4x
thymosin beta 4, X-linked
decreases expression
EXP
muraglitazar results in decreased expression of TMSB4X mRNA
CTD
PMID:21515302
NCBI chr X:27,144,666...27,146,667
Ensembl chr X:27,128,610...27,146,667
G
Tmt1b
thiol methyltransferase 1B
increases expression
EXP
muraglitazar results in increased expression of METTL7B mRNA
CTD
PMID:21515302
NCBI chr 7:1,388,876...1,391,526
Ensembl chr 7:1,388,879...1,391,526
G
Tnfaip2
TNF alpha induced protein 2
decreases expression
EXP
muraglitazar results in decreased expression of TNFAIP2 mRNA
CTD
PMID:21515302
NCBI chr 6:130,476,832...130,489,914
Ensembl chr 6:130,476,889...130,489,914
G
Tnfrsf9
TNF receptor superfamily member 9
increases expression
EXP
muraglitazar results in increased expression of TNFRSF9 mRNA
CTD
PMID:21515302
NCBI chr 5:161,381,662...161,408,003
Ensembl chr 5:161,381,662...161,408,000
G
Tor3a
torsin family 3, member A
increases expression
EXP
muraglitazar results in increased expression of TOR3A mRNA
CTD
PMID:21515302
NCBI chr13:68,769,893...68,798,738
Ensembl chr13:68,769,605...68,798,475
G
Tpo
thyroid peroxidase
decreases expression
EXP
muraglitazar results in decreased expression of TPO mRNA
CTD
PMID:21515302
NCBI chr 6:46,698,402...46,768,199
Ensembl chr 6:46,698,414...46,768,199
G
Trim54
tripartite motif-containing 54
decreases expression
EXP
muraglitazar results in decreased expression of TRIM54 mRNA
CTD
PMID:21515302
NCBI chr 6:25,239,340...25,258,511
Ensembl chr 6:25,239,340...25,258,511
G
Tsku
tsukushi, small leucine rich proteoglycan
increases expression
EXP
muraglitazar results in increased expression of TSKU mRNA
CTD
PMID:21515302
NCBI chr 1:152,660,259...152,671,682
Ensembl chr 1:152,656,693...152,672,588
G
Txnip
thioredoxin interacting protein
increases expression
EXP
muraglitazar results in increased expression of TXNIP mRNA
CTD
PMID:21515302
NCBI chr 2:184,093,079...184,096,882
Ensembl chr 2:184,092,991...184,096,886
G
Ucp2
uncoupling protein 2
increases expression
EXP
muraglitazar results in increased expression of UCP2 mRNA
CTD
PMID:21515302
NCBI chr 1:154,839,242...154,845,612
Ensembl chr 1:154,839,209...154,845,611
G
Ugt1a1
UDP glucuronosyltransferase family 1 member A1
increases glucuronidation
ISO
UGT1A1 protein results in increased glucuronidation of muraglitazar
CTD
PMID:17898154
NCBI chr 9:88,801,344...88,808,465
Ensembl chr 9:88,713,184...88,808,465
G
Ugt1a2
UDP glucuronosyltransferase 1 family, polypeptide A2
increases glucuronidation
ISO
UGT1A3 protein results in increased glucuronidation of muraglitazar
CTD
PMID:17898154
NCBI chr 9:88,791,216...88,808,465
Ensembl chr 9:88,713,184...88,808,465
G
Ugt1a9
UDP glucuronosyltransferase family 1 member A9
increases glucuronidation
ISO
UGT1A9 protein results in increased glucuronidation of muraglitazar
CTD
PMID:17898154
NCBI chr 9:88,696,981...88,808,465
Ensembl chr 9:88,713,184...88,808,465
G
Ugt2b1
UDP glucuronosyltransferase 2 family, polypeptide B1
decreases expression
EXP
muraglitazar results in decreased expression of UGT2B1 mRNA
CTD
PMID:21515302
NCBI chr14:21,024,035...21,035,784
Ensembl chr14:21,024,006...21,035,986
G
Unc5b
unc-5 netrin receptor B
increases expression
EXP
muraglitazar results in increased expression of UNC5B mRNA
CTD
PMID:21515302
NCBI chr20:28,697,726...28,764,474
Ensembl chr20:28,697,726...28,764,537
G
Ush1c
USH1 protein network component harmonin
decreases expression
EXP
muraglitazar results in decreased expression of USH1C mRNA
CTD
PMID:21515302
NCBI chr 1:96,695,303...96,743,671
Ensembl chr 1:96,695,307...96,743,671
G
Usp2
ubiquitin specific peptidase 2
increases expression
EXP
muraglitazar results in increased expression of USP2 mRNA
CTD
PMID:21515302
NCBI chr 8:44,411,457...44,439,668
Ensembl chr 8:44,411,607...44,438,331
G
UST4r
integral membrane transport protein UST4r
decreases expression
EXP
muraglitazar results in decreased expression of UST4R mRNA
CTD
PMID:21515302
NCBI chr 1:205,072,204...205,142,718
Ensembl chr 1:205,072,296...205,142,691
G
Vcam1
vascular cell adhesion molecule 1
decreases expression
EXP
muraglitazar results in decreased expression of VCAM1 mRNA
CTD
PMID:21515302
NCBI chr 2:204,038,120...204,057,852
Ensembl chr 2:204,038,114...204,057,958
G
Vipr1
vasoactive intestinal peptide receptor 1
decreases expression
EXP
muraglitazar results in decreased expression of VIPR1 mRNA
CTD
PMID:21515302
NCBI chr 8:121,303,739...121,339,587
Ensembl chr 8:121,310,248...121,339,585
G
Vldlr
very low density lipoprotein receptor
increases expression
EXP
muraglitazar results in increased expression of VLDLR mRNA
CTD
PMID:21515302
NCBI chr 1:224,813,539...224,850,400
Ensembl chr 1:224,814,377...224,845,920
G
Vnn1
vanin 1
increases expression
EXP
muraglitazar results in increased expression of VNN1 mRNA
CTD
PMID:21515302
NCBI chr 1:21,537,084...21,547,395
Ensembl chr 1:21,537,094...21,547,395
G
Vom2r-ps45
vomeronasal 2 receptor, pseudogene 45
decreases expression
EXP
muraglitazar results in decreased expression of VOM2R-PS45 mRNA
CTD
PMID:21515302
NCBI chr 1:66,463,177...66,490,650
Ensembl chr 1:66,463,277...66,490,550
G
Vom2r44
vomeronasal 2 receptor 44
increases expression
EXP
muraglitazar results in increased expression of VOM2R44 mRNA
CTD
PMID:21515302
NCBI chr 2:148,497,150...148,536,036
Ensembl chr 2:148,500,170...148,531,880
G
Vom2r65
vomeronasal 2 receptor, 65
increases expression
EXP
muraglitazar results in increased expression of VOM2R65 mRNA
CTD
PMID:21515302
G
Xirp1
xin actin-binding repeat containing 1
decreases expression
EXP
muraglitazar results in decreased expression of XIRP1 mRNA
CTD
PMID:21515302
NCBI chr 8:119,744,778...119,757,547
Ensembl chr 8:119,747,419...119,757,349
G
Ypel4
yippee-like 4
decreases expression
EXP
muraglitazar results in decreased expression of YPEL4 mRNA
CTD
PMID:21515302
NCBI chr 3:69,815,373...69,820,708
Ensembl chr 3:69,816,175...69,820,707
G
Zdhhc18
zinc finger DHHC-type palmitoyltransferase 18
decreases expression
EXP
muraglitazar results in decreased expression of ZDHHC18 mRNA
CTD
PMID:21515302
NCBI chr 5:145,821,534...145,859,989
Ensembl chr 5:145,831,446...145,859,993
G
Zfp354a
zinc finger protein 354A
increases expression
EXP
muraglitazar results in increased expression of ZFP354A mRNA
CTD
PMID:21515302
NCBI chr10:35,396,242...35,408,069
Ensembl chr10:35,396,231...35,408,068
G
Zfp365
zinc finger protein 365
decreases expression
EXP
muraglitazar results in decreased expression of ZFP365 mRNA
CTD
PMID:21515302
NCBI chr20:20,666,240...20,689,734
Ensembl chr20:20,666,240...20,691,238
G
Zfp37
zinc finger protein 37
increases expression
EXP
muraglitazar results in increased expression of ZFP37 mRNA
CTD
PMID:21515302
NCBI chr 5:75,598,732...75,638,896
Ensembl chr 5:75,598,732...75,638,942
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all